Stockwinners Market Radar for November 15, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
ACN | Hot Stocks21:11 EST Accenture acquires Solnet, terms not stated - The company states: "Accenture has agreed to acquire Solnet, an IT services provider with deep technology consulting experience for New Zealand government and private organizations across multiple industries. Terms of the transaction were not disclosed. With headquarters in Wellington, New Zealand, Solnet's team of more than 100 technologists will join Accenture. Solnet's services and solutions will bolster Accenture's local cloud and infrastructure engineering offerings, helping clients tap into a full continuum of technical capabilities to accelerate their digital transformation."
|
AXP | Hot Stocks20:24 EST American Express reports October Consumer Card net write-offs 1.9% - In a regulatory 8-K filing earlier this morning, American Express announced Consumer Card net write-offs at 1.9% vs. 1.7% in September and U.S. Small Business Card Member loans write-offs at 2.0% vs. 1.7% in September.
|
AEY | Hot Stocks19:50 EST ADDvantage trading halted, news pending
|
BMY | Hot Stocks19:33 EST Bristol Myers announces FDA approves Augtyro in NSCLC treatment - Bristol Myers Squibb announced that the FDA approved Augtyro, or repotrectinib, for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer, or NSCLC. Administered as an oral therapy, Augtyro is a tyrosine kinase inhibitor (TKI) targeting ROS1 oncogenic fusions. The approval is based on the TRIDENT-1 study, an open-label, single-arm, Phase 1/2 trial that evaluated Augtyro in TKI-naive and TKI-pretreated patients. In TKI-naive patients, the primary endpoint of objective response rate, or ORR, defined as the percentage of people treated within a certain period of time whose tumor size decreased or who no longer have signs of cancer, was 79%. The median duration of response was 34.1 months. Among patients pretreated with one prior ROS1 TKI and no prior chemotherapy, the ORR was 38% and the mDOR was 14.8 months. Among those who had measurable central nervous system metastases at baseline, responses in intracranial lesions were observed in 7 of 8 TKI-naive patients and 5 of 12 of those who were TKI-pretreated. The FDA-approved dosing for Augtyro is 160 mg orally once daily for 14 days, then increased to 160 mg twice daily until disease progression or unacceptable toxicity.
|
CSCO | Hot Stocks18:46 EST Cisco CEO: We have really cleared our backlog over the last quarter - In an interview on CNBC's Mad Money, Chuck Robbins said due to all of the inventory shipped in Q1, customers have not been able to absorb it. He expects things to improve in 2H24. "There are a lot of positives in the second half of the year," he noted. The company has "effectively passed" the antitrust scenario with respect to the Splunk acquisition, he said.
|
GRWG | Hot Stocks18:46 EST GrowGeneration CEO buys $994K in common stock as part of option expiry - In a regulatory filing, GrowGeneration disclosed that its CEO Darren Lampert bought 496K shares of common stock on November 13th in a total transaction size of $994K as part of option expiry.
|
JANX | Hot Stocks18:42 EST Janux Therapeutics up 3.5% on insider buying activity disclosed afterhours
|
JANX | Hot Stocks18:41 EST Janux Therapeutics Acting CFO buys $4.99M in common stock - In a regulatory filing, Janux Therapeutics disclosed that its Acting CFO Tighe Reardon bought 850K shares of common stock on November 13th in a total transaction size of $4.99M.
|
JANX | Hot Stocks18:40 EST Janux Therapeutics director buys $4.99M in common stock - In a regulatory filing, Janux Therapeutics disclosed that its director Jay Lichter bought 850K shares of common stock on November 13th in a total transaction size of $4.99M.
|
ALPMY | Hot Stocks18:39 EST Astellas Pharma to acquire Propella Therapeutics for roughly $175M - Astellas Pharma and Propella Therapeutics announced that Astellas, through a U.S. subsidiary, and Propella have entered into a merger agreement pursuant to which Astellas will acquire Propella. Propella is a privately held biopharmaceutical company that has leveraged a wholly owned proprietary platform that combines medicinal chemistry with lymphatic targeting to create new oncology drugs. Under the agreement, Astellas will pay approximately $175M to acquire all of the outstanding common stock and equity interests in Propella. Subject to customary closing conditions, the transaction is expected to occur during Astellas' fiscal year 2023. The impact of this transaction on Astellas' financial results in the fiscal year ending March 31, 2024, will be limited.
|
PANW | Hot Stocks18:38 EST Palo Alto Networks CEO: We had a great quarter, there is tremendous demand - In an interview on CNBC's Mad Money, Nikesh Arora said, "There is tremendous demand out there and prospects are bright." The company has the ability to finance deals and there's lots of cash on the balance sheet, he added. RPO is a better indicator of performance in the future, not billings, he noted.
|
PANW | Hot Stocks18:35 EST Palo Alto Networks CEO: We had a great quarter, there is tremendous demand - In an interview on CNBC's Mad Money, Nikesh Arora said, "There is tremendous demand out there and prospects are bright." The company has the ability to finance deals and there's lots of cash on the balance sheet, he added. RPO is better indicator of performance in the future, not billings, he noted.
|
BILL | Hot Stocks18:02 EST Bill director buys $1.0M in common stock - In a regulatory filing, Bill Holdings disclosed that its director David Hornik bought 17.7K shares of common stock on November 13th in a total transaction size of $1.0M.
|
GRMN | Hot Stocks17:50 EST Garmin CEO Pemble sells 5,000 registered shares - In a regulatory filing, Garmin president and CEO Clifton Pemble disclosed the sale of 5,000 registered shares of the company on November 15 at a price of $120 per share.
|
WRK | Hot Stocks17:37 EST WestRock director Ford buys $424K in company shares - Westrock Coffee director Joe Ford disclosed the purchase of 52,005 shares of company stock at $8.16 per share, between November 14 and November 15, for a total transaction amount of $424,137.
|
SONO | Hot Stocks17:37 EST Sonos sees H1 representing 51%-53% of FY24 revenue - Says guidance assumes weak consumer demand in Q4 persists throughout FY24, with the low end assuming trends soften somewhat further. Says expects to exit Q1 in better inventory position. Comments taken from Q4 earnings conference call.
|
LMT | Hot Stocks17:36 EST Lockheed Martin awarded $100.89M Army contract modification - Lockheed Martin was awarded a $100.89M modification to a contract for HIMARS/MLRS fire control systems and launcher-loader module logistics support. Work has an estimated completion date of December 31, 2025. FY10 operation and maintenance, defense-wide funds in the amount of $6.72M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.
|
MATW | Hot Stocks17:29 EST Matthews increases quarterly dividend - Matthews International Corporation announced that its Board of Directors declared, at its regularly scheduled meeting today, a dividend of 24c per share on the Company's common stock, representing an increase to the Company's quarterly dividend rate.Joseph C. Bartolacci, President and Chief Executive Officer, stated: "We continue to maintain a strong cash flow profile facilitating ongoing support of our long-term growth objectives. This represents our 30th consecutive annual dividend increase since becoming a publicly-traded company." The dividend is payable December 11 to stockholders of record November 27.
|
AMPH | Hot Stocks17:24 EST Amphastar Director Prins sells $263K in company shares - Amphastar Director Richard Prins disclosed the sale of 5,000 shares of company stock at $52.50 per share on November 13, for a total transaction amount of $262,500.
|
LZ | Hot Stocks17:08 EST LegalZoom director sells $163.7M in common stock - In a regulatory filing, LegalZoom disclosed that its director Dipan Pantel sold 15.1M shares of common stock on November 13th in a total transaction size of $163.7M.
|
HOLI | Hot Stocks17:08 EST Hollysys reports $256.4M in new contracts for 1Q - Hollysys achieved $256.4M in terms of the value of new contracts for the three months ended September 30. The order backlog of contracts as of September 30 was $938.6M.
|
DDD | Hot Stocks17:04 EST 3D Systems expects restructuring phase to reduce OpEx by about $45M-455M in 2024 - According to a regulatory filing, 3D Systems initiated the next phase of its multi-faceted restructuring initiative designed to improve operating efficiencies throughout the organization and drive long-term value creation, as announced on October 25. The company expects this phase of the restructuring initiative will reduce operating expenses by approximately $45M-$55M in 2024, with the majority of the cost takeout to occur by the end of the first quarter of 2024. The company expects to incur cash charges in the range of $4M to $6M predominantly related to severance costs. The company may incur additional charges in 2024 as it finalizes all of the actions to be taken.
|
AIT | Hot Stocks17:03 EST Applied Industrial Technologies exec Loring sells 5,470 common shares - In a regulatory filing, Applied Industrial Technologies chief HR officer Kurt Loring disclosed the sale of 5,470 common shares of the company on November 14 at a price of $164.495 per share.
|
TWTR | Hot Stocks16:59 EST FAA has gives authorization for 2nd SpaceX launch Starship Super Heavy vehicle - "The FAA has given license authorization for the second launch of the @SpaceX...Starship Super Heavy vehicle. The FAA determined SpaceX met all safety, environmental, policy and financial responsibility requirements." Elon Musk of X (TWTR) controls SpaceX, a privately held space exploration company. https://twitter.com/FAANews/status/1724899056315777260
|
CSCO | Hot Stocks16:51 EST Cisco sees Q2 gross margin 65%-66% - Sees Q2 operating margin 31.5%-32.5%. Sees Q2 and FY24 tax rate 19%. Says Q1 product orders declined 20%. Says bottleneck in supply chain has shifted downstream to implementation. Says one to two quarters of orders awaiting implementation. Says delivered solid quarter. Says expects to close Splunk acquisition by end of Q3 in 2024. Comments and guidance taken from Q1 earnings conference call.
|
USDP | Hot Stocks16:50 EST USD Partners announces suspended NYSE trading - USD Partners LP announced that the Partnership received notification from the New York Stock Exchange that the NYSE will suspend trading of, and commence proceedings to delist, the Partnership's common units, effective at the open of business eastern standard time on November 16, 2023. The determination was made in connection with the Partnership's non-compliance with an NYSE listing requirement necessitating an average market capitalization of at least $15M over a consecutive 30 trading-day period. The Partnership has 10 business days to determine whether to appeal the NYSE's delisting determination. The suspension and delisting determination do not affect the Partnership's business, nor do they conflict with or cause an event of default under the Partnership's Credit Agreement.
|
F... | Hot Stocks16:50 EST NTSB calls for speed assistance tech in all new cars after Nevada collision - The National Transportation Safety Board investigation into a multivehicle collision in North Las Vegas, Nevada, last year that resulted in nine fatalities has led the board to recommend a requirement for intelligent speed assistance technology in all new cars. The board issued the recommendations Tuesday at a public board meeting after determining the crash was caused by excessive speed, drug-impaired driving and Nevada's failure to deter the driver's speeding recidivism due to systemic deficiencies, despite numerous speeding citations. Intelligent speed assistance technology, or ISA, uses a car's GPS location compared with a database of posted speed limits and its onboard cameras to help ensure safe and legal speeds. Passive ISA systems warn a driver when the vehicle exceeds the speed limit through visual, sound, or haptic alerts, and the driver is responsible for slowing the car. Active systems include mechanisms that make it more difficult, but not impossible, to increase the speed of a vehicle above the posted speed limit and those that electronically limit the speed of the vehicle to fully prevent drivers from exceeding the speed limit. "This crash is the latest in a long line of tragedies we've investigated where speeding and impairment led to catastrophe, but it doesn't have to be this way," said NTSB Chair Jennifer Homendy. "We know the key to saving lives is redundancy, which can protect all of us from human error that occurs on our roads. What we lack is the collective will to act on NTSB safety recommendations." Publicly traded companies in the space include Ford (F), General Motors (GM), Honda (HMC), Mercedes-Benz Group (DDAIF), Nissan (NSANY), Stellantis (STLA), Tesla (TSLA), Toyota (TM) and Volkswagen (VWAGY). Reference Link
|
PI | Hot Stocks16:47 EST Sylebra Capital discloses purchase of $2.46M of Impinj common shares - In a regulatory filing, Sylebra Capital disclosed that its bought 33.7K share of Impinj common stock on November 13th in a total transaction size of $2.46M.
|
CF | Hot Stocks16:43 EST CF Industries announces HSR period expiration for Waggaman facility acquisition - CF Industries announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, in connection with its agreement to purchase Incitec's ammonia production complex located in Waggaman, Louisiana. The expiration of the HSR Act waiting period was a condition to the closing of the pending transaction. CF Industries and IPL expect to complete the transaction effective December 1, , subject to the satisfaction of other customary closing conditions. CF Industries will purchase the Waggaman ammonia plant and related assets for $1.675B. The companies will allocate approximately $425M of the purchase price to a long-term ammonia offtake agreement under which CF Industries will supply up to 200K tons of ammonia per year to IPL's Dyno Nobel subsidiary at production economics. CF Industries expects to fund the remaining $1.25B of the purchase price with cash on hand.
|
PEP | Hot Stocks16:43 EST NYAG James files lawsuit against PepsiCo over single-use plastic packaging - New York Attorney General Letitia James filed a historic and groundbreaking lawsuit against PepsiCo for harming the public and the environment with its single-use plastic packaging. The Office of the Attorney General OAG found that single-use plastic produced by PepsiCo contributes significantly to high levels of plastic pollution along the Buffalo River, pollution that is contaminating drinking water and harming wildlife. The lawsuit alleges that PepsiCo substantially causes public harm in Buffalo, has failed to warn consumers about the potential health and environmental risks of its single-use plastic packaging, and misleads consumers and the public about its efforts to combat plastic pollution. Through this lawsuit, Attorney General James seeks to require PepsiCo to end practices that threaten the environment and the public and to obtain disgorgement, civil penalties, and restitution for the damage inflicted upon New York's communities and environment. Reference Link
|
MAXN | Hot Stocks16:43 EST Maxeon Solar falls 9.5% after Q3 earnings miss, FY23 guidance cut
|
PANW | Hot Stocks16:38 EST Palo Alto Networks falls 9% after Q1 results - Shares of Palo Alto Networks are down 9% or $23.18 at $233 despite Q1 earnings beat, above-consensus Q2 guidance.
|
NVTA | Hot Stocks16:36 EST Aranscia acquires select assets of YouScript from Invitae, terms not disclosed - Aranscia, a global provider of diagnostics software, services, and testing solutions, and Invitae Corporation announced that Aranscia has acquired select assets of the YouScript personalized medication management platform from Invitae Corporation in an all-cash transaction. YouScript is a player in providing actionable, real-time medication risk and pharmacogenomics insights that enable healthcare providers and organizations to build, deliver, and scale comprehensive personalized medication management programs. YouScript will join the Aranscia portfolio of companies, each of which shares a synergistic mission of solving the tactical gaps in clinical workflows and democratizing access to the promises of precision medicine. This portfolio includes 2bPrecise, the award-winning suite of lab-agnostic, EMR-integrated solutions for PGx, population health insights, and precision oncology workflows; SinguLab, a national network of diagnostics services support; and AccessDx Laboratory, a CLIA-certified, CAP accredited, and NYCQ molecular diagnostic laboratory with specialist expertise in PGx operations. "We warmly welcome the YouScript team and platform to the Aranscia family," said Joe Spinelli, Chief Strategy Officer of Aranscia. "As one of the foundational innovators in PGx, YouScript has long served as a model contributor to advancing the practical utilization of PGx for clinical professionals as well as measuring the profound impact of PGx programs in improving overall healthcare outcomes. We're committed to supporting the continued success of YouScript at Aranscia and look forward to collaboration with our other portfolio assets to help YouScript efficiently support clinical PGx programs for providers and organizations around the world."
|
ESTC | Hot Stocks16:36 EST Elastic to acquire Opster - Elastic announced an agreement to acquire Opster, the creators of AutoOps, a platform that provides deep insight to automatically detect and resolve issues with cluster health, improve search performance, and reduce hardware costs. Opster co-founder and CEO, Ziv Segal, and key staff will be joining Elastic. Financial terms of the transaction were not disclosed. Completion of the acquisition is subject to customary closing conditions.
|
PRMW | Hot Stocks16:32 EST Primo Water names Robbert Rietbroek as CEO - Primo Water announced that its Board of Directors has appointed Robbert Rietbroek as CEO and to the Board of Directors, effective January 1, 2024. The appointment concludes a comprehensive CEO search process, launched by the Board following Tom Harrington's decision to retire, with the mandate to appoint a highly capable leader with extensive product innovation, operational and transformational experience, capable of further driving growth across Primo Water's businesses for years to come.
|
USDP | Hot Stocks16:32 EST NYSE to commence delisting proceedings against USD Partners - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common units representing limited partner interests of USD Partners LP - ticker symbol USDP - from the NYSE. Trading in the company's common units will be suspended immediately. "The company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the common units upon completion of all applicable procedures, including any appeal by the company of the NYSE Regulation staff's decision," the exchange stated. Reference Link
|
CSCO | Hot Stocks16:28 EST Cisco saw 'slowdown of new product orders' in Q1 - Cisco saw a slowdown of new product orders in the first quarter of fiscal 2024 and believes the primary reason is that customers are currently focused on installing and implementing products in their environments following exceptionally strong product delivery over the past three quarters. Cisco estimates there are one to two quarters of shipped product orders still waiting to be implemented by its customers.
|
MRCY | Hot Stocks16:23 EST Mercury Systems' President of Mission Systems division Dr. Stevison to depart - Mercury Systems announced the departure of Dr. Mitch Stevison, Executive Vice President and President of Mercury's Mission Systems division, effective December 1. Dr. Stevison will pursue a new opportunity outside of the company. Mercury Chairman and CEO Bill Ballhaus will lead the Mission Systems team until a permanent leader is identified. Dr. Stevison joined Mercury as Executive Vice President and Chief Growth Officer in October 2021 and became Executive Vice President and President of Mercury's Mission Systems Division in October 2022.
|
NXTC | Hot Stocks16:19 EST NextCure publishes manuscript regarding NC525 - NextCure announced the publication of a manuscript titled "LAIR-1 Agonism as a Therapy for Acute Myeloid Leukemia" in the Journal of Clinical Investigation. The data demonstrate that NC525 induces cell death in acute myeloid leukemia, or AML, blast cells and leukemic stem cells, or LSCs, through leukocyte-associated immunoglobin-like receptor-1, or LAIR-1, agonism by driving a unique apoptotic signaling pathway. NC525 is a humanized monoclonal antibody, or mAb, that specifically binds to LAIR-1 and kills LSCs, while sparing healthy hematopoietic stem cells, or HSCs. The publication details a novel mechanism for the potential treatment of AML, as the expression level of the LAIR-1 receptor on leukemic cells acts as a key regulator. High expression of LAIR-1 is commonly seen on LSCs and blast cells and plays a role in survival of these cancer cells. In contrast, LAIR-1 expression is relatively lower on healthy HSCs and does not play a role in survival of normal immune cells. This makes LAIR-1 a promising anti-leukemic target. In addition to its potential therapeutic effects as a monotherapy, the publication highlights that NC525 synergizes with, and improves the activity of, ventoclax and azacytidine, or VEN-AZ, the current SoC therapy in AML. The combination kills leukemic cells from patients refractory to VEN-AZ. Thus, NC525 holds great promise as an important and novel treatment for patients with resistant and refractory AML. A Phase 1 study with NC525 is underway as an open-label, non-randomized, dose escalation trial to determine safety and tolerability of NC525 in adult patients with relapsed or refractory AML.
|
WSBC | Hot Stocks16:17 EST WesBanco raises quarterly dividend 2.9% to 36c per share - WesBanco announced that its Board of Directors has approved a 2.9% increase in the quarterly cash dividend to 36c per common share from the previous quarterly dividend of 35c per common share. The higher dividend rate will be payable on January 2, 2024 to shareholders of record on December 8, 2023. This is the seventeenth increase in the quarterly dividend since 2010, and represents a cumulative increase of 157% over that period.
|
AIG | Hot Stocks16:16 EST AIG names Roshan Navagamuwa CIO - AIG announced that Roshan Navagamuwa will be joining AIG in December and has been named EVP and Chief Information Officer, effective January 1, 2024. Mr. Navagamuwa will report to Peter Zaffino, AIG Chairman & Chief Executive Officer, and serve on AIG's Executive Leadership Team. As Chief Information Officer, Mr. Navagamuwa will be responsible for AIG's global technology and cybersecurity strategy, managing core infrastructure, technology partnerships and process engineering efforts, and lead AIG's cloud strategy along with other modernization technologies. Zaffino said: "Roshan is an accomplished technology executive with an impressive track record of innovating software development and managing through complex organizational change. I am very pleased that Roshan is joining AIG, and his deep expertise and broad management experience will be an asset as we continue to strategically deploy technology to advance our next phase of growth."
|
MHO | Hot Stocks16:16 EST M/I Homes announces $100M increase to share repurchase program - M/I Homes announced that its Board of Directors approved an increase in its share repurchase authorization by an additional $100M. As of September 30, 2023, $53M was available under the previous authorizations.
|
MAXN SPWR | Hot Stocks16:14 EST Maxeon Solar, SunPower announce supply agreement - Maxeon Solar Technologies (MAXN) and SunPower (SPWR) announced an amendment of their supply agreement and resolution of disputes between the companies. As part of the amended agreement, Maxeon will supply modules to SunPower through February 2024. SunPower will maintain its exclusive right to distribute M-Series products in the U.S. until March 31, 2024. Maxeon will be released from non-circumvention obligations with respect to SunPower dealers and will receive warrants to purchase SunPower common stock in a private placement, subject to the provisions of the agreement. Additionally, all outstanding disputes regarding the Master Supply Agreements between the two companies have been resolved.
|
TTEK | Hot Stocks16:13 EST Tetra Tech up 2% at $162.00 after Q4 earnings beat and guidance
|
ARDX | Hot Stocks16:13 EST FDA grants Ardelyx ODD for XPHOZAH or tenapanor for Pediatric Hyperphosphate - Ardelyx announced that the U.S. Food and Drug Administration FDA has granted Orphan Drug Designation to XPHOZAH or tenapanor, for the treatment of pediatric hyperphosphatemia. XPHOZAH is a single tablet taken twice daily that offers a first-in-class mechanism of action that blocks phosphate absorption through its primary pathway. "We are pleased that the FDA has recognized the important need among pediatric patients with hyperphosphatemia for treatment options," said Mike Raab, president and chief executive officer of Ardelyx. "This designation highlights the importance of evaluating treatment options for all patients with hyperphosphatemia, and we look forward to sharing more details on this important designation by FDA in the future." The FDA's Orphan Drug Designation supports the development and evaluation of new drugs or biological products to prevent, diagnose or treat rare diseases or conditions that affect fewer than 200,000 people in the U.S. Orphan Drug benefits can include potential market exclusivity for seven years after approval, exemption from user fees and tax credits for qualified clinical trials. In October, XPHOZAH was approved by the FDA to reduce serum phosphorus in adults with chronic kidney disease CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
|
KLIC | Hot Stocks16:12 EST Kulicke & Soffa receives orders for Thermocompression Bonding solutions - Kulicke and Soffa Industries announced that the company has received multiple orders for its Thermocompression Bonding solutions, primarily supporting Silicon Photonics based Co-Packaged Optics applications deployed in high-bandwidth networking transceivers. K&S anticipates a series of follow on CPO orders to support aggressive capacity expansion plans throughout fiscal years 2024 and 2025. CPO units are anticipated to grow at a 66% CAGR through calendar year 2033 and represent only an individual component to the much larger Artificial Intelligence opportunity.
|
HOOD | Hot Stocks16:12 EST Robinhood reports October operating data - Reports assets under custody, or AUC, at the end of October were $84.6B, down 2% from September. Net deposits were $1B in October, translating to a 14% annualized growth rate relative to September 2023. Trading volumes in October were higher for equities, options, and crypto compared to September. Margin balances at the end of October were $3.5B, down 3%. Cash sweep balances at the end of October were $13.9B.
|
KLIC | Hot Stocks16:11 EST Kulicke & Soffa raises quarterly dividend to 20c from 19c per share - This dividend raise marks the 4th consecutive annual dividend raise and highlights the company's consistent shareholder return strategy. This upcoming dividend payment will be made on January 9, 2024 to holders of record as of December 21, 2023.
|
UVE | Hot Stocks16:10 EST Universal Insurance declares 13c per share special dividend - The dividend is payable on December 15, 2023 to shareholders of record as of the close of business on December 8, 2023.
|
MANH | Hot Stocks16:09 EST Manhattan Associates CLO Richards sells 4,535 common shares - In a regulatory filing, Manhattan Associates CLO Bruce Richards disclosed the sale of 4,535 common shares of the company on November 14 at a price of $220.4163 per share.
|
CSCO | Hot Stocks16:08 EST Cisco falls 11% to $47.25 after lowering FY24 guidance
|
RGP | Hot Stocks16:07 EST Resources Connection acquires CloudGo Pte Ltd. - On November 15, 2023, Resources Connection closed a transaction to acquire 100% of the equity of CloudGo Pte Ltd. and its subsidiaries. Headquartered in Singapore, CloudGo is a digital transformation firm and one of the fastest growing Elite ServiceNow Partners. CloudGo will be combined with RGP's Veracity business and will accelerate the expansion of RGP's digital presence across the Asia Pacific region. Founded in 2016 by Rahul Garg and Rory Fitzpatrick, CloudGo rapidly grew its expert capabilities, achieving ServiceNow Elite Partner status in just two years. Today the firm has nearly 80 employees and operations in Singapore, Australia and India. CloudGo is on track to achieve significant revenue growth in 2023.
|
SONO | Hot Stocks16:06 EST Sonos announces $200M buyback program - Sonos "announced that its Board of Directors has authorized a common stock repurchase program of up to $200 million. Since September 2019, the company has completed $350 million in stock repurchases, including its most recent $100 million stock repurchase program which it completed in the fourth quarter of fiscal 2023. Under its most recently completed authorization, the company repurchased approximately 6.6 million shares at an average price of $15.25 per share, enabling the company to return capital to shareholders and offset dilution from compensation plans."
|
USDP | Hot Stocks16:04 EST USD Partners trading halted, news pending
|
MOR | Hot Stocks16:04 EST MorphoSys narrows FY23 Monjuvi U.S. net product sales to $85M-$95M - Prior guidance was $80M-$95M. Lowers gross margin for Monjuvi U.S. net product sales to about 75% from 75%-80%.
|
A | Hot Stocks16:03 EST Agilent raises quarterly dividend 5% to 23.6c per share - Agilent Technologies announced the company has increased its quarterly dividend to 23.6c per share of common stock, a 5% increase over the previous dividend. The quarterly dividend will be paid on Jan. 24, 2024, to all shareholders of record as of the close of business on Jan. 2, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent's board of directors.
|
SMRT | Hot Stocks16:01 EST SmartRent names Daryl Stemm CFO - SmartRent announced the appointment of Daryl Stemm as its Chief Financial Officer. Stemm, who has served as the Company's senior vice president of finance since 2021, brings four decades of experience in finance, accounting, treasury and risk management to the role. "We are pleased to appoint Daryl as CFO for SmartRent," said SmartRent CEO Lucas Haldeman. "He has been an integral part of our team, helping SmartRent scale and grow to become the leading provider in our space. We look forward to continuing to benefit from his leadership and experience as our CFO."
|
BETS | Hot Stocks16:01 EST Bit Brother Limited receives Nasdaq delisting letter - Bit Brother Limited announced that it has received a notice from the NASDAQ Stock Market notifying the company that the Nasdaq Staff had determined to delist the company's securities from Nasdaq based upon the Company's non-compliance with Nasdaq Listing Rule 5550(a)(2) and 5810(c)(3)(A)(iii), as the Company's securities had a closing bid price of $0.10 or less for 11 consecutive trading days from October 26 through November 9, 2023. The notice has no immediate impact on the Company's listing and trading, as the Company intends to request a hearing before the Panel by November 17, 2023. Such request will stay any suspension or delisting action by Nasdaq pending the completion of the hearing process There can be no assurance that the Panel will grant the Company's request for additional time to demonstrate compliance of continued listing requirement or that the Company will be able meet the continued listing requirement during any compliance period or in the future. If the Panel does not grant the Company's request for additional time, its ordinary shares will be subject to delisting and the liquidity and marketability of the Company's ordinary shares would be adversely affected.
|
UFPI | Hot Stocks15:35 EST UFP Industries director William Currie sells 20,000 common shares - In a regulatory filing, UFP Industries director William Currie disclosed the sale of 20,000 common shares of the company on November 15 at a price of $112.59 per share.
|
PKTEF | Hot Stocks14:56 EST Parkit Enterprise acquires Winnipeg facility for $6.5M cash - Parkit Enterprise has agreed to acquire an industrial building located in Winnipeg, Manitoba from a vendor for an aggregate purchase price of $6,500,000, subject to customary adjustments. The Vendor is not a related party to Parkit and the Acquisition constitutes an Arm's Length Transaction for the purposes of the TSX Venture Exchange policies. The purchase price for the Acquisition is $6,500,000, subject to adjustments. The Property has a building which is approximately 82,400 square feet on approximately 4.6 acres of land, is partially tenanted and is located close to Winnipeg Richardson International Airport. The purchase price will be satisfied with funds on hand. Depending on the satisfaction of certain closing conditions, closing is expected to occur in Q1 of 2024. Iqbal Khan, CEO of Parkit, states, "The Acquisition provides in-place cash flows, strong potential rental growth and adds scale to our existing Winnipeg portfolio with excellent upside."
|
JGGC | Hot Stocks14:54 EST Jaguar Global Growth Corporation I trading resumes
|
META | Hot Stocks14:47 EST Meta Platforms' Instagram discloses new tools for content creation - In an earlier blog posting, Instagram disclosed new tools to take content creation to the "next level..." The company is "announcing a number of improvements to Reels, exciting new updates for feed photos & carousels, Stories, and new insights to help you better understand your performance. Key updates include: Saving time editing your videos with new tools like Undo / Redo that make it easier to edit individual clips and Make new memes by adding clips with audio to your Reels from our new Media Clip hub. Also the company said it will add "new and inspiring ways to create Reels on Instagram. Also announced was "10 new English text-to-speech voices to select from, available in select countries, a streamlined view of all your saved drafts for easier editing "in your in-progress Reels." Also mentioned in the post were the latest filters "from subtle color edits to options for expressive styles, these updates make it easy for you to try various looks for your posts." Reference Link
|
FAST | Hot Stocks14:28 EST Fastenal CEO Daniel Florness sells $1.2M inciompany shares - The Fastenal CEO, Daniel Florness, disclosed in a filing that he had sold 20,000 shares of company stock at $60.21 per share on November 14, for a total transaction amount of $1,204,128.
|
MNSO | Hot Stocks14:22 EST Miniso opens 20 new stores in U.S. amid expansion, sees 15 more by year-end - "Global lifestyle brand MINISO has unveiled over 20 new stores in the United States in recent months, as the Company continues its robust expansion in the world's largest economy with presence in more than 20 states. In an effort to offer fun and functional lifestyle products to more customers, MINISO has entered 10 new states so far this year, - namely Michigan, Oregon, South Carolina, Arizona, Connecticut, Louisiana, Maine, Georgia, Indiana, Oklahoma. Specifically, the brand successfully opened five new stores in October alone, with one of them located in Castleton Square Mall, the largest shopping center in Indiana...Looking ahead, MINISO plans to open at least 15 more stores in the U.S. by the end of the year and push ahead with its brand upgrade strategy. For example, the Company this year introduced the concepts of "Super Store," "Super IP," and "Super Product." The global flagship store at Times Square in New York has played a pivotal role in showcasing these initiatives and achieved outstanding performance. As part of the strategy, MINISO has rolled out products featuring popular IPs such as Barbie, Snoopy, Disney 100 and Sanrio," the company said in an earlier release.
|
RBLX | Hot Stocks14:20 EST Roblox targeting 2025-2027 annual bookings growth of 20%-plus - Guidance from Roblox investor day meeting.
|
JGGC | Hot Stocks14:14 EST Jaguar Global Growth Corporation I trading halted, volatility trading pause
|
FUSB | Hot Stocks14:11 EST First US Bancshares' board extends existing share buyback to December 31, 2024 - First US Bancshares announced that its Board of Directors has extended the Company's existing share repurchase program. The share repurchase program, which was previously set to expire on December 31 has been extended to expire on December 31, 2024. The Company has repurchased 1,045,972 shares of its common stock to date under the repurchase program and 596,813 shares remain available for repurchase. The Company most recently repurchased shares pursuant to the program during the third quarter of 2022. Share repurchases under the repurchase program may be made through open market transactions, through privately negotiated transactions or otherwise at times and in such amounts as management deems appropriate, subject to applicable regulatory requirements. Open market purchases may be executed through a pre-arranged repurchase plan that operates in accordance with the guidelines specified under Rule 10b5-1 and Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The repurchase program does not obligate the Company to acquire any particular number of shares and may be suspended at any time at the Company's discretion.
|
RBLX | Hot Stocks14:05 EST Roblox up 6% as company hosts investor day meeting - Shares of Roblox are up $2.30, or 6%, to $41.54 as of 2:05 PM EST as the company hosts its investor day meeting. Reference Link
|
CSGP | Hot Stocks14:05 EST CoStar expands France operations with Sandra Roumi as France General Manager - CoStar Group announced the appointment of Sandra Roumi as its first France General Manager, to lead the Group's France expansion efforts. After serving as the Editor-in-Chief of all platforms at Business Immo, Roumi was appointed its Deputy President and Director of Publications in 2018. In her new role as General Manager of CoStar Group in France, she will advance the company's mission and launch CoStar and LoopNet to the French market. "I am thrilled to continue CoStar Group's expansion in France, part of our continuing successful effort to introduce industry-leading data, analytics, insights and online marketplaces into European markets," said Andy Florance, Founder and Chief Executive Officer of CoStar Group. "Sandra's unparalleled knowledge of - and respect within - the French commercial real estate industry makes her the perfect choice to lead this endeavor." The continued expansion in France is part of the company's European growth strategy. CoStar Group already has international operations in 15 countries globally, including the United Kingdom, Spain and Germany as well as in France. CoStar Group's combined France operations will be headquartered at 81 rue Taitbout, in the 9th arrondissement of Paris.
|
CNI... | Hot Stocks13:43 EST North American rail traffic up 3.8% for the week ending November 11 - The Association of American Railroads or AAR reported U.S. rail traffic for the week ending November 11. For this week, total U.S. weekly rail traffic was 497,348 carloads and intermodal units, up 3.4% compared with the same week last year. Total carloads for the week ending November 11 were 233,745 carloads, up 2.3% compared with the same week in 2022, while U.S. weekly intermodal volume was 263,603 containers and trailers, up 4.4% compared to 2022. Seven of the 10 carload commodity groups posted an increase compared with the same week in 2022. They included coal, up 1,793 carloads, to 69,213; motor vehicles and parts, up 1,707 carloads, to 16,542; and metallic ores and metals, up 1,520 carloads, to 19,705. Commodity groups that posted decreases compared with the same week in 2022 were nonmetallic minerals, down 1,168 carloads, to 31,294; farm products excl. grain, and food, down 113 carloads, to 16,801; and chemicals, down 95 carloads, to 30,673. North American rail volume for the week ending November 11 on 12 reporting U.S., Canadian and Mexican railroads totaled 347,446 carloads,up 4.5% compared with the same week last year, and 345,647 intermodal units, up 3.2% compared with last year. Total combined weekly rail traffic in North America was 693,093 carloads and intermodal units, up 3.8%. North American rail volume for the first 45 weeks of 2023 was 29,526,956 carloads and intermodal units, down 3.2% compared with 2022. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), Trinity Industries (TRN), Greenbrier (GBX), FreightCar America (RAIL), Wabtec (WAB) and Rail Vision (RVSN). Reference Link
|
TALK | Hot Stocks13:22 EST Talkspace powering 'TeenSpace' program in NYC - New York City Mayor Eric Adams and New York City Department of Health and Mental Hygiene Commissioner Dr. Ashwin Vasan announced "TeenSpace," the city's tele-mental health service available to all New York City teenagers between the ages of 13 and 17 years old at no cost. "Launching this month, the service - created in partnership with online therapy platform Talkspace - will allow New York City teenagers to connect with a licensed therapist through phone, video, and text," the city and the company announced.
|
DAL | Hot Stocks13:18 EST Delta Air Lines projects 6.2M-6.4M customers over Thanksgiving period - Official Delta projections put the total estimated customer count between 6.2M and 6.4M from Friday, Nov. 17-Tuesday, Nov. 28, averaging 515,000-530,000 customers a day, the company stated in a post to its corporate news hub. Reference Link
|
ALEX | Hot Stocks13:16 EST Alexander & Baldwin sells Grace Pacific to Nan, terms not disclosed - Alexander & Baldwin has sold Grace Pacific to Nan. A&B acquired Grace Pacific in 2013. Grace Pacific has been an integral force in Hawai'i's infrastructure growth for over nine decades, providing a reliable local source of construction materials and playing a pivotal role in the development and maintenance of critical infrastructure such as roads, highways, runways, and harbors that connect our island communities.
|
CRMD | Hot Stocks12:59 EST CorMedix announces FDA approval of DefenCath - CorMedix announced that the U.S. Food and Drug Administration has approved DefenCath catheter lock solution to reduce the incidence of catheter-related bloodstream infections for the limited population of adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. "DefenCath is the first and only FDA-approved antimicrobial CLS in the U.S. and was shown to reduce the risk of CRBSIs by up to 71% in a Phase 3 clinical study," the company stated. Joseph Todisco, CEO of CorMedix commented, "The approval of DefenCath marks a major advancement in reducing life-threatening infections for patients receiving hemodialysis via central venous catheters and an important milestone for CorMedix. As the first FDA-approved antimicrobial catheter lock solution designed to prevent CRBSIs, DefenCath offers healthcare providers an option to reduce the risk of infections in a patient population already vulnerable due to underlying kidney failure. We thank all the patients, caregivers, clinical investigators, and our employees who have played an integral role in the development and regulatory approval of DefenCath. Our commercial team along with our broader organization is preparing for commercial launch, and we look forward to working with healthcare providers and facilities to give hemodialysis patients access to DefenCath in early 2024."
|
TKO | Hot Stocks12:56 EST TKO Group CEO Emanuel buys 12,531 class A shares - In a regulatory filing, TKO Group CEO Ariel Emanuel disclosed the purchase of 12,531 class A common shares of the company on November 14 at a price of $79.80 per share.
|
TKO | Hot Stocks12:55 EST TKO Group COO Shapiro buys 12,531 class A shares - In a regulatory filing, TKO Group president and COO Mark Shapiro disclosed the purchase of 12,531 class A common shares of the company on November 14 at a price of $79.80 per share.
|
TKO | Hot Stocks12:54 EST TKO Group director McMahon sells 8.4M class A shares - In a regulatory filing, TKO Group director Vincent McMahon disclosed the sale of 8.4M class A common shares of the company on November 14 at a price of $76.41 per share.
|
SONY... | Hot Stocks12:04 EST Sony's 'Spider-Man 2' top selling game in U.S. in October, says Circana - Circana analyst Mat Piscatella said that Sony's (SONY) "Marvel's Spider-Man 2" was the best-selling game of October in the U.S., instantly becoming the 4th best-selling game of 2023 year-to-date. "Marvel's Spider-Man 2" also led all titles in physical software dollar sales during October. Launch month dollar sales of" Marvel's Spider-Man 2" exceeded those of September 2018's "Marvel's Spider-Man" by a double-digit percentage. Nintendo's (NTDOY) "Super Mario Bros. Wonder" debuted as the #2 best-selling game of October 2023. It currently ranks as the 21st best-selling game of 2023 year-to-date, though Piscatella noted that digital sales for Nintendo published titles are not inluded in the title sales ranking charts. Roblox (RBLX) was released on PlayStation platforms during October and ranked 4th across all titles on PlayStation 5 in U.S. monthly active users, according to Circana's Player Engagement Tracker, trailing only Activision's (MSFT) "Call of Duty: Modern Warfare II," Epic's "Fortnite" and "Marvel's Spider-Man 2." Other top sellers for the month were Ubisoft's (UBSFY) "Assassin's Creed Mirage," Electronic Arts' (EA) "Madden NFL 24" and "EA Sports FC 24," and Warner Bros. Discovery's (WBD) "Mortal Kombat 1." Investors in Epic include Tencent (TCEHY), KKR (KKR), Disney (DIS), and Sony. Reference Link
|
MSFT... | Hot Stocks12:01 EST U.S. video game consumer spending fell 5% y/y in October, says Circana - Circana analyst Mat Piscatella said that U.S. consumer spending on video game content, hardware and accessories in October fell 5% vs YA, to $4B. Declines were experienced across all categories of spend. The dip was partially driven by Call of Duty shifting release months. Year-to-date U.S. consumer spending across video game products remained 2% higher than a year ago, at $43.4B. Spending on video game content in October fell 4% when compared to a year ago, to $3.6B. Growth in physical console software and mobile spending was offset by declines in other areas, particularly digital premium downloads driven by the release date shift of "Call of Duty." Publicly traded companies in the space include Microsoft (MSFT), SOny (SONY), Electronic Arts (EA), GameStop (GME), Nintendo (NTDOY), Take-Two (TTWO), Tencent (TCEHY) and Ubisoft (UBSFY).
|
NU | Hot Stocks12:00 EST Nu Holdings falls -7.9% - Nu Holdings is down -7.9%, or -70c to $8.13.
|
ENR | Hot Stocks12:00 EST Energizer falls -8.5% - Energizer is down -8.5%, or -$3.08 to $33.04.
|
ML | Hot Stocks12:00 EST MoneyLion falls -9.7% - MoneyLion is down -9.7%, or -$3.38 to $31.34.
|
CHGG | Hot Stocks12:00 EST Chegg rises 15.4% - Chegg is up 15.4%, or $1.37 to $10.26.
|
TGT | Hot Stocks12:00 EST Target rises 16.9% - Target is up 16.9%, or $18.72 to $129.51.
|
PKST | Hot Stocks12:00 EST Peakstone Realty Trust rises 17.0% - Peakstone Realty Trust is up 17.0%, or $2.54 to $17.50.
|
NGS | Hot Stocks11:59 EST Natural Gas Services up after reporting Q3 results - Shares of Natural Gas Services Group are up $2.11, or 15%, to $16.02 in Wednesday morning trading after the company reported revenue for the three months ended September 30, 2023 increased 42.3% to $31.4M from $22.0M for the three months ended September 30, 2022. This increase was due primarily to an increase in rental revenues. The company reported net income of $2.2M, or 18c per basic share, as compared to a net loss of $80,000 in the third quarter of 2022 and net income of $504,000 in the second quarter of 2023. Commenting on the quarter, Stephen Taylor our Chairman and Interim CEO, added: "We had a very successful third quarter. Our total revenue increased over 16% from the prior quarter with a year over year increase of 42%. These increases were lead by rental revenues that grew by $3.6M, or 15%, sequentially and $9.1M, or 49%, when compared to last year's third quarter. Sales and Aftermarket Services revenue, combined being about 12% of total revenue, grew sequentially by approximately $0.8M or 28%. Between the second and third quarters of this year, total gross margins grew by 14%. From the prior quarter, SG&A declined by over $2M or 41% and operating income was up almost six times to $4.9M. Sequential net income increased by over three times from the prior quarter and EBITDA grew 19% to $11.8M. In the comparative year over year periods we saw similar growth dynamics and cost savings. Our 2023 capital program is proceeding as planned and, as we experienced in the last quarter, is continuing to show exceptional and positive financial impact."
|
COIN | Hot Stocks11:28 EST Coinbase says sends are delayed for Polygon - Coinbase stated in a system status message: "Sends are delayed for Polygon. While we work on a fix, your funds remain secure." Reference Link
|
TJX | Hot Stocks11:25 EST TJX sees FY24 adjusted gross margin 29.6%
|
TJX | Hot Stocks11:20 EST TJX sees Q4 pretax profit margin 10.4%-10.6%
|
AMD MSFT | Hot Stocks11:07 EST AMD says Instinct MI300X Accelerators to power new Microsoft Azure VMs - At Microsoft Ignite, AMD (AMD) and Microsoft (MSFT) featured how AMD products, including the upcoming AMD Instinct MI300X accelerator, AMD EPYC CPUs and AMD Ryzen CPUs with AI engines, are "enabling new services and compute capabilities across cloud and generative AI, Confidential Computing, Cloud Computing and smarter, more intelligent PCs," AMD stated. "AMD is fostering AI everywhere - from the cloud, to the enterprise and end point devices - all powered by our CPUs, GPUs, accelerators and AI engines. Together with Microsoft and a rapidly growing ecosystem of software and hardware partners, AMD is accelerating innovation to bring the benefits of AI to a broad portfolio of compute engines, with expanding software capabilities," said Vamsi Boppana, Senior Vice President, AI, AMD. "Microsoft's new Azure ND MI300x v5 Virtual Machine, or VM, series optimized for AI workloads features the AMD Instinct MI300X, making Azure the first cloud to use the new accelerator. The new VMs are part of Microsoft's diverse infrastructure supporting AI innovation for enterprises everywhere giving customers more choice in efficiency and scalability," AMD added.
|
TJX | Hot Stocks11:04 EST TJX's Q4 off to a strong start, says CEO - Comments taken from Q3 earnings conference call.
|
SU | Hot Stocks11:03 EST Suncor increases quarterly dividend 5% to C$0.545 per share - Last night, Suncor Energy announced that its board of directors has approved a quarterly dividend of C$0.545 per share on its common shares, representing an increase of approximately 5% over the prior quarter dividend. The dividend will be payable December 22 to shareholders of record at the close of business on December 1. "The increase is supported by our improved operational performance and is consistent with our focus on growing free funds flow to support strong shareholder returns, which includes a sustainable and competitive dividend," said Rich Kruger, Suncor President and CEO.
|
PPBN | Hot Stocks11:03 EST Pinnacle Bankshares increases cash dividend to 25c per share - Pinnacle Bankshares Board of Directors declared a cash dividend of 25c per share on November 14, 2023, payable December 8, 2023, to shareholders of record as of November 24, 2023. The 25c per share cash dividend is an increase of 5c per share, or 25%, compared to the 20c per share cash dividend paid last quarter and marks the forty-fifth consecutive quarter that a dividend has been declared.
|
SPTN | Hot Stocks11:01 EST SpartanNash names DexKo CEO Fred Bentley as independent director - SpartanNash announced the appointment of current DexKo Global, Inc. President and CEO Fred Bentley to the Board of Directors. "Fred is a well-rounded leader and seasoned CEO with global supply chain, food and manufacturing experience that will be highly additive to our Board," said SpartanNash Board Chairman Douglas Hacker. SpartanNash refreshed its Board in 2022 with the addition of three independent directors who replaced three directors who did not seek reelection. This year, Bentley is the second independent director to join the Board, following the August appointment of Kerrie MacPherson.
|
PRE | Hot Stocks10:51 EST Prenetics Global Ltd trading resumes
|
KHC | Hot Stocks10:44 EST Kraft Heinz announces updates to executive leadership team - The Kraft Heinz Company announced new members of its Executive Leadership Team that will partner with Carlos Abrams-Rivera when he assumes the CEO role beginning in the 2024 fiscal year. As previously announced, Pedro Navio will be elevated to President, North America. Navio has been with Kraft Heinz since 2017, most recently in the role of President of Taste, Meals, and Away from Home in North America. Willem Brandt will be elevated to the role of President, Europe and Pacific Developed Markets. Brandt has been at Kraft Heinz since 2021 in the role of Continental Europe President. Bruno Keller will be elevated to the role of President, West and East Emerging Markets. Keller has been with Kraft Heinz since 2014 and has held several roles, including Managing Director for South Europe, President, Canada, and most recently, President, Latin America. Cory Onell will be elevated to Chief Omnichannel Sales & Asia Emerging Markets Officer. Onell will lead global omnichannel sales and go-to-market capabilities and tools to unlock growth across developed and emerging markets. Because of the uniqueness of Asia, specifically with its Go-To-Market Model, Asia Emerging Markets will be a standalone zone led by the Omnichannel Officer. Onell has been with Kraft Heinz since 2020 in the role of President of U.S. Sales. Diana Frost will be elevated to Chief Growth Officer. Frost will be responsible for accelerating growth globally through the Company's long-term plan, building brands through marketing excellence, and transforming the product portfolio through disruptive innovation. Frost has been with Kraft Heinz since 2020, most recently as Chief Growth Officer for North America.
|
PRE | Hot Stocks10:41 EST Prenetics Global Ltd trading halted, volatility trading pause
|
HARL | Hot Stocks10:37 EST Harleysville Financial announces special cash dividend of $1.20 per share - Harleysville Financial reported that the company's Board of Directors declared a special cash dividend of $1.20 per share on the company's common stock. The special cash dividend will be payable on December 13, 2023 to shareholders of record on November 29, 2023. President and CEO Brendan J. McGill stated, "With the company's record earnings of $12,223,000, increased earnings per share and underlying strength of our balance sheet this past year; the Board is pleased to be able to declare this special cash dividend on the common stock. The nonrecurring special dividend is indicative of the company's continued commitment to enhance shareholder value."
|
UBS | Hot Stocks10:12 EST French Supreme Court refers UBS legavy matter to Appeals Court - The French Supreme Court issued a judgement on a legacy matter related to UBS's cross-border business activities in France between 2004 and 2012. The Supreme Court upheld the previous court decision regarding unlawful client solicitation and aggravated laundering of the proceeds of tax fraud, while overturning the confiscation of EUR 1bn, the fine of EUR 3.75m and EUR 800m in civil damages awarded to the French state. The case is now being referred back to the Paris Court of Appeal, which will reconsider the overturned elements and deliver its judgement after a new trial. While UBS is pleased that the highest court in France agrees with its position on these important aspects of the legal case, UBS is disappointed that the French Supreme Court has confirmed the previous court decision regarding unlawful client solicitation and aggravated laundering of the proceeds of tax fraud despite the treaty between Europe and Switzerland on the taxation of savings income and a lack of specific evidence for the alleged facts. UBS continues to maintain that it acted in accordance with all applicable laws and regulations at all times. UBS will defend itself in the forthcoming trial.
|
AAPL GSAT | Hot Stocks10:11 EST Apple extending Emergency SOS via satellite for iPhone 14 users for another year - Apple (AAPL) CEO Tim Cook said via X, the platform formerly known as Twitter, "A year ago today, we launched Emergency SOS via satellite. Today, we're extending free access to this lifesaving technology for existing iPhone 14 users for another year." "Emergency SOS via satellite has helped save lives around the world. From a man who was rescued after his car plummeted over a 400-foot cliff in Los Angeles, to lost hikers found in the Apennine Mountains in Italy, we continue to hear stories of our customers being able to connect with emergency responders when they otherwise wouldn't have been able to," said Kaiann Drance, Apple's vice president of Worldwide iPhone Product Marketing, in a statement. "We are so happy iPhone 14 and iPhone 15 users can take advantage of this groundbreaking service for two more years for free." Globalstar's (GSAT) satellite network and ground stations ensures iPhone 14 users are able to connect to emergency services when off the grid. Reference Link
|
OMQS | Hot Stocks10:07 EST Omniq announces order for Machine Vision solution - OMNIQ Corp. announced that the Company's AI-based Machine Vision solution is being ordered for an upgrade program at the Port Authority of New York and New Jersey four major airports. The Company and its partner DESIGNA are working together on a collaborative agreement to further the success of PANYNJ. The collaboration completes a technology upgrade of the VRS-Vehicle Recognition Systems at four airports, including the addition of the latest AI neural network deep learning engine developed by omniQ's scientists.
|
ENR | Hot Stocks10:00 EST Energizer falls -9.5% - Energizer is down -9.5%, or -$3.43 to $32.69.
|
NU | Hot Stocks10:00 EST Nu Holdings falls -9.5% - Nu Holdings is down -9.5%, or -83c to $8.00.
|
ZIM | Hot Stocks10:00 EST ZIM Integrated falls -10.5% - ZIM Integrated is down -10.5%, or -82c to $6.98.
|
VFC | Hot Stocks10:00 EST VF Corp. rises 11.8% - VF Corp. is up 11.8%, or $1.83 to $17.40.
|
SAVE | Hot Stocks10:00 EST Spirit Airlines rises 11.7% - Spirit Airlines is up 11.7%, or $1.16 to $11.11.
|
TGT | Hot Stocks10:00 EST Target rises 16.8% - Target is up 16.8%, or $18.58 to $129.37.
|
PENN DIS | Hot Stocks09:59 EST Penn announces ESPN BET successfully launched in 17 U.S. states - PENN Entertainment (PENN) announced that ESPN BET successfully launched in the 17 states across the U.S. where it offers online sports betting. In addition, PENN's online casino offering is now accessible within ESPN BET via mobile and web under the Hollywood Casino brand in Michigan, New Jersey, Pennsylvania and West Virginia. In August, PENN entered into an exclusive long-term strategic alliance with Disney's (DIS) ESPN and ESPN Enterprises relating to online sports betting within the United States. "We're extremely proud to introduce ESPN BET and look forward to delivering an exceptional customer experience to fans across the U.S. Our successful launch is the culmination of months of hard work across both teams and we could not be more excited to roll out ESPN BET in partnership with ESPN. PENN's operational excellence paired with ESPN's unmatched brand and reach is a powerful combination that will drive this compelling new sportsbook.," said Jay Snowden, CEO and President, PENN Entertainment.
|
ZIM | Hot Stocks09:47 EST ZIM Integrated falls -9.0% - ZIM Integrated is down -9.0%, or -70c to $7.10.
|
NU | Hot Stocks09:47 EST Nu Holdings falls -9.3% - Nu Holdings is down -9.3%, or -82c to $8.01.
|
XYF | Hot Stocks09:47 EST X Financial falls -10.7% - X Financial is down -10.7%, or -46c to $3.83.
|
LIND | Hot Stocks09:47 EST Lindblad rallies 4% to $7.54 after expanded National Geographic pact
|
HLLY | Hot Stocks09:47 EST Holley rises 7.9% - Holley is up 7.9%, or 33c to $4.45.
|
VFC | Hot Stocks09:47 EST VF Corp. rises 9.8% - VF Corp. is up 9.8%, or $1.53 to $17.10.
|
TGT | Hot Stocks09:47 EST Target rises 13.2% - Target is up 13.2%, or $14.58 to $125.37.
|
SNES | Hot Stocks09:41 EST SenesTech announces reverse stock split - SenesTech announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. The reverse stock split will become effective at 4:01 p.m, Eastern Time, on November 16, 2023. The company's common stock will continue to be traded on the Nasdaq Capital Market under the symbol "SNES" and will begin trading on a split-adjusted basis when the market opens on November 17, 2023. At a special meeting of stockholders held on August 18, 2023, the company's stockholders granted the company's Board of Directors the discretion to effect a reverse stock split of the company's common stock through an amendment to its Amended and Restated Certificate of Incorporation, as amended, at a ratio of not less than 1-for-2 and not more than 1-for-12, with such ratio to be determined by the company's Board of Directors.
|
BTAI | Hot Stocks09:32 EST BioXcel raises 'substantial doubt' about continuing as going concern - In its quarterly filing with the SEC yesterday, BioXcel Therapeutics said it "identified conditions and events that raise substantial doubt about our ability to continue as a going concern." The company's reprioritization was approved by the board on August 8, but such plans will not mitigate the entity's ability to continue as a going concern within one year after the date that the financial statements are issued, BioXcel wrote. As of September 30, the company had cash and cash equivalents of $89,961 and an accumulated deficit of $568,342. BioXcel noted it has incurred substantial net losses and negative cash flows from operating activities in nearly every fiscal period since inception and expects this trend to continue for the foreseeable future. The shares are up 3% to $4.35 in early trading.
|
ENB | Hot Stocks09:27 EST Enbridge announces participation at Fox Squirrel solar project - Enbridge announced that it has signed a definitive agreement to participate in the construction and operation of the Fox Squirrel solar project, through a 50% interest in a joint venture with EDF Renewables. Fox Squirrel is a ground-mounted solar facility under construction in Madison County, Ohio. The initial phase is expected to generate approximately 150 MW of solar energy and be in service by year-end. The project will be constructed in three phases and is designed to ultimately deliver up to 577 MW of renewable energy to the utility grid by the end of 2024. Enbridge will invest $149M in the first phase and plans to reach final investment decision on the following phases throughout 2024, assuming certain conditions are met. The project has 20-year fixed-price power purchase agreements with a strong investment grade counterparty for the full generation capacity.
|
SNPS MSFT | Hot Stocks09:26 EST Synopsys announces Synopsys.ai Copilot - Synopsys (SNPS) announced a breakthrough generative artificial intelligence capability for accelerating chip design, Synopsys.ai Copilot. The new capability is the result of a strategic collaboration with Microsoft (MSFT) to integrate Azure OpenAI Service that brings the power of GenAI into one of the most complex engineering challenges - the design process for semiconductors.
|
CAR | Hot Stocks09:25 EST Avis Budget announces intention to offer $500M of senior notes - Avis Budget Group announced that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. intend, subject to market and other customary conditions, to offer $500 million aggregate principal amount of senior notes due 2031 in a private offering. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of its U.S. subsidiaries. The Company intends to use the net proceeds from the Notes offering to redeem all of the outstanding 4.500% senior notes due 2025 issued by Avis Budget Finance plc, repay a portion of its floating rate term loan C maturing in 2029 and pay fees and expenses in connection with the foregoing, with the remainder to be used for general corporate purposes.
|
PYPL | Hot Stocks09:24 EST PayPal to establish three new business units - To establish clear accountability in how PayPal serves end-to-end customer needs, the company is establishing three new business units aligned to the customers it serves: Consumer, Small Business, and Large Enterprise. "By organizing our teams into defined business units, we focus on what's most important to our customers, leverage the power of our data and platform to deliver with increased speed, and package our innovation in a way that differentiates us in the market. This will position us to drive meaningful growth for the company," said Alex Chriss, President and CEO of PayPal
|
EXPE | Hot Stocks09:23 EST Expedia rallies 1% to $124.05 after Reuters report of ValueAct position
|
PYPL WMT | Hot Stocks09:18 EST PayPal announces executive leadership changes - PayPal Holdings (PYPL) announced senior leadership changes that underscore the company's commitment to building a high-performing organization, serving its customers, and driving profitable growth. Isabel Cruz will join PayPal as Chief People Officer, effective November 27. Michelle Gill is joining PayPal as EVP, General Manager of a newly formed Small Business and Financial Services Group, effective today. Diego Scotti will join PayPal as EVP, General Manager of a newly formed Consumer Group and Global Marketing & Communications organization, effective December 4. Positioning for its next phase of growth, Cruz will be accountable for attracting, retaining, and developing talent at PayPal as well as the company's global real estate strategy. Cruz joins PayPal from Walmart (WMT) where she was most recently SVP and People Leader for Walmart's Global Technology, Services & Corporate teams, leading talent strategies and people initiatives supporting more than 30,000 associates, globally. Scotti will be accountable for bringing PayPal's breadth of consumer products and services together in a cohesive, integrated, and seamless customer experience and value proposition. He will also lead PayPal's global marketing and communications to drive enhanced brand awareness and use for PayPal and Venmo. Scotti joins PayPal from Verizon where he was most recently EVP and Chief Marketing Officer. Scotti previously served as CMO at J.Crew and prior to that held top marketing roles at Vogue and American Express. Gill will be accountable for bringing together the ecosystem of products and services that help small business owners run and grow their businesses into a unified offering. Gill was previously SVP, QuickBooks Money Platform at Intuit.
|
LAES | Hot Stocks09:16 EST SEALSQ Corp. to offer countries opportunity to develop own semiconductor centers - SEALSQ announced that it is revolutionizing the semiconductor landscape by offering countries the opportunity to develop their own Semiconductor Personalization Centers through Public-Private Partnerships. This groundbreaking initiative aims to mitigate global dependency on semiconductor manufacturing and fortify microchip deployment capabilities. Carlos Moreira, CEO of SEALSQ, emphasizes the strategic significance: "In today's tech-driven world, control over semiconductor supply is not just an economic advantage, it's a national security imperative. Our initiative empowers countries to establish local semiconductor personalization centers, ensuring uninterrupted access to these critical components."
|
HUGE | Hot Stocks09:15 EST FSD Pharma files information circular in connection with Special Meeting - FSD Pharma has provided certain additional disclosure, by way of a Supplement dated November 15, 2023 to its Management Information Circular dated October 20, 2023, relating to certain restrictions on resale that will apply to the Celly Nu Shares that will be distributed to the FSD Pharma Securityholders. Capitalized terms not defined in this news release have the meanings assigned in the Circular.
|
AWRE | Hot Stocks09:15 EST Aware, Serban Group announce partnership for biometric identity solutions - The partnership announced between Aware and Serban Group will bolster the delivery of biometric digital identity and authentication solutions to financial services firms, governments and commercial enterprises in the LATAM and European regions. "Aware's solutions, both on-prem and SaaS-based, are industry-leading and recognized the world over for their exceptional accuracy and demographic parity," says Craig Herman, chief revenue officer at Aware. "This partnership will enable our companies to jointly create leading-edge, highly advanced and secure biometric authentication solutions for enterprises, governments and financial services institutions in these key markets."
|
SSNT | Hot Stocks09:14 EST SilverSun Technologies acquires JCS Computer Resource Corporation - SilverSun Technologies announced that its wholly-owned subsidiary, SWK Technologies, Inc., has acquired substantially all the business assets of JCS Computer Resource Corporation, a leading Illinois-based reseller of Sage Software solutions. Over the last 35 years, JCS has implemented technology applications at prominent manufacturers, distributors and professional service organizations throughout the Midwest. SilverSun's subsidiary, SWK Technologies, is one of the largest Sage business partners in North America. The acquisition of JCS expands SWK's geographic footprint and adds over 350 Sage 100 customers to our already substantial customer base.
|
PBPB | Hot Stocks09:14 EST Potbelly announces 22-shop agreement in Seattle-Tacoma region - Potbelly announced the completion of a deal that will expand the company's presence in the greater Seattle-Tacoma region of Washington state. As the company continues to execute its long-term growth strategy, with franchise deals underway across the U.S., this agreement will increase the total number of shops in the area to 22 in partnership with Sound Sandwich LLC, a locally based, experienced franchisee. The agreement includes the transfer of ownership of nine existing restaurants. Additionally, the franchisee will develop 13 new units in King, Pierce, and Thurston counties over the next eight years. "We're thrilled to put the Potbelly experience within the reach of more people in the Seattle-Tacoma region," said Bob Wright, President and CEO of Potbelly. "This is a market that performs well but is significantly underpenetrated right now. We see tremendous whitespace for our brand and look forward to supporting our franchisee as they open the doors to new shops in the years ahead."
|
PVCT | Hot Stocks09:13 EST Provectus provides updated data from Phase 1b/2 trial of PV-10 - Provectus provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 in combination with standard of care immune checkpoint blockade for the treatment of advanced cutaneous melanoma. Initial results from CB-naive patients in the main study cohort illustrated potential clinical benefit across all stages of metastasis. Longer-term follow-up of an expanded patient population has been assessed. Participants must have had at least 1 injectable lesion and at least 1 measurable target lesion and been a candidate for pembrolizumab. The combination of PV-10 and pembrolizumab was administered every 3 weeks for up to 5 cycles, followed by pembrolizumab alone every 3 weeks for a total duration of up to 24 months. Patients may have received PV-10 as needed beyond the initial treatment course per investigator discretion. The primary endpoint of the Phase 1b portion was safety and tolerability. Objective response rate and progression-free survival were key secondary endpoints. The addition of an expansion cohort balanced overall enrollment at 25 patients: Median age 73.0 years, range 28-82, 20 male, 5 female, and 6 Stage IIIB-IIIC, 8 Stage IV M1a, 7 M1b, 4 M1cper the American Joint Committee on Cancer melanoma staging system. Treatment-emergent adverse events were consistent with the established patterns of both study drugs. There was no evidence of overlap. For all CB-naive patients: ORR was 72%; 20% complete response and 52% partial response, Median PFS was 12.5 months for all patients, Median overall survival was 37.6 months, and Median disease-specific survival was 64.4 months. For CB-naive Stage III patients: ORR was 83%; 50% CR and 33% PR, CRs were rapid and durable, having been reached within 15 weeks by 2 patients and within 27 weeks by the third, and are ongoing after 24-44 months of follow-up, mPFS has not been reached, mOS is estimated to be 36.3 months, mDSS is estimated to be 42.5 months, and Both survival metrics could be affected by the status of the last patient in the cohort who is an ongoing complete responder at 30.1 months.
|
SCLX | Hot Stocks09:11 EST Scilex announces issuance of new patent in U.S. for ZTlido - Scilex Holding announced that the U.S. Patent and Trademark Office has issued a new patent, No. 11,793,766, further strengthening the Company's intellectual property position and coverage for its lead commercial product, ZTlido 1.8%. The Patent, titled "Non-aqueous Patch for the Relief of Pain," covers a method of relieving pain through the application of a lidocaine-containing patch. "The newly issued Patent demonstrates our commitment to offer innovative, non-opioid pain management products and to develop meaningfully differentiated programs that address significant unmet needs leading to improved health outcomes for the millions of acute and chronic pain patients. Our growing intellectual property portfolio provides significant barriers of entry, protects us from would be competitors, and gives us confidence in long-term growth opportunity for ZTlido(R)," said Jaisim Shah, Chief Executive Officer and President of Scilex.
|
NRXS | Hot Stocks09:10 EST Neuraxis announces CareFirst BCBS policy coverage - NeurAxis announced receipt of CareFirst Blue Cross Blue Shield policy coverage for the mid-Atlantic region with 3.5 million lives. CareFirst BCBS is the largest healthcare insurer in the mid-Atlantic that includes Maryland, Washington DC, and Northern Virginia.
|
ALPN | Hot Stocks09:10 EST Alpine Immune Sciences presents data for povetacicept in SLE at ACR Convergence - Alpine Immune Sciences announced that the Company presented new translational data for povetacicept in systemic lupus erythematosus or SLE at the American College of Rheumatology Convergence 2023..Povetacicept Presentation Highlights Include: In SLE patients, BAFF- and APRIL-related genes are increased in myeloid lineage cells and B cells compared to healthy adults. Povetacicept, as compared to single BAFF or APRIL pathway inhibitors, more potently downregulates genes associated with activation in B cells. Povetacicept significantly reduces multiple disease parameters in a mouse model of lupus, more effectively than WT TACI-Fc or conventional B cell depletion.
|
CTRM | Hot Stocks09:09 EST Castor Maritime announces completion of sale of M/V Magic Sun - Castor Maritime announces that on November 14, 2023, the Company completed the previously announced sale at a price of $6.55 million of the M/V Magic Sun, a 2001-built Panamax bulk carrier vessel, by delivering the vessel to its new owner. The Company expects to record during the fourth quarter of 2023 a net gain on the sale of the M/V Magic Sun of approximately $1.0 million, excluding any transaction-related costs.
|
WISH | Hot Stocks09:08 EST ContextLogic expands LaaS arm with launch of WishPost Smart Parcel - ContextLogic announced the launch of WishPost Smart Parcel - a Logistics as a Service, Laas, product that is designed to provide a seamless and efficient shipping solution to non-Wish merchants, ensuring rapid, reliable, and cost-effective deliveries. WishPost Smart Parcel's end-to-end small parcel delivery service leverages Wish's global network of Logistics Service Providers which spans first mile, international line haul, customs brokerage and last mile delivery. Designed to meet the needs of non-Wish merchants, the innovative service underpins Wish's commitment to delivering operational excellence. "As a global online marketplace that works with an extensive network of sellers worldwide, we have made it our mission to build a world-class logistics network that can stand up to scrutiny," said Bill Zhang, VP of Global Logistics, Wish. "The launch of WishPost Smart Parcel marks a significant milestone in our journey as we deepen our investment in our logistics capabilities, in order to broaden the impact of our top-tier service that combines unbeatable value with speed."
|
INMB | Hot Stocks09:07 EST INmune Bio announces expansion of Phase II trial for AD in Europe - INmune Bio has received acceptance of a Clinical Trial Application, CTA, under EU Clinical Trials Regulation to initiate a Phase II trial in Early Alzheimer's Disease, AD, with XPro in Poland. Additional regulatory approval for the Phase II AD clinical trial is expected from at least two to potentially six more EU countries in the upcoming months. The EU approval is part of the Company's international clinical development strategy for XPro in patients with early AD. The trial is currently enrolling patients in Australia, Canada, and the United Kingdom. "We are delighted with the addition of clinical sites in the EU. Countries were selected based on their previous experience in Alzheimer's disease research and their interest in novel therapies," said RJ Tesi M.D., CEO of INmune Bio. "Broadening the clinical presence in the EU serves dual purposes. First, it addresses the near-term objective of completing enrollment of the Phase II trial. Additionally, the initiation of sites in the EU establishes the groundwork for realizing our long-term goal of conducting a global Phase III trial."
|
AMD | Hot Stocks09:07 EST AMD announces AMD Instinct MI300 Accelerator Launch Event - AMD announced "Advancing AI," an in-person and livestreamed event on December 6, 2023 to launch the next-generation AMD Instinct MI300 data center GPU accelerator family and highlight the Company's growing momentum with AI hardware and software partners. AMD Chair and CEO Dr. Lisa Su will be joined by AMD executives, AI ecosystem partners and customers who will discuss how AMD products and software are re-shaping the AI, adaptive and high-performance computing landscape.
|
ZUO | Hot Stocks09:05 EST Zuora and Avalara expand partnership with integrated E-invoicing solution - Zuora expanded its partnership with Avalara which will provide Zuora customers with access to Avalara E-Invoicing and Live Reporting. Countries around the world continue to adopt e-invoicing mandates as well as additional digital reporting requirements, such as live reporting of invoice data and e-reporting of international sales and purchases. But compliance is often complex and costly, as timelines and regulations vary by country. The expanded partnership between Zuora and Avalara will help equip companies to meet these requirements with an integrated solution. "Zuora's partnership with Avalara arms modern businesses with the technology necessary today to pursue recurring growth on a global scale," said Balaji Subramanian, Vice President, Global Partner Ecosystem at Zuora. "Now, our joint customers will be able to meet varying e-invoicing and live reporting requirements through Zuora." With Avalara E-Invoicing and Live Reporting, Zuora customers will be able to: Set up global e-invoicing capabilities: Zuora customers can set up Avalara E-Invoicing and Live Reporting, set up their credentials, and configure it based on their reporting needs.
|
SYT | Hot Stocks09:05 EST Syla Technologies enters agreement for business alliance with RIBERESUTE - SYLA Technologies has entered into an agreement to acquire 2,158,800 shares of common stock of RIBERESUTE CORPORATION, a Japan-based developer and seller of family-type condominiums and a corporation listed on the Tokyo Stock Exchange, through off-market transactions from four of its shareholders. SYLA expects that the Share Acquisition will make it the largest shareholder of RIBERESUTE. The Share Acquisition is subject to certain closing conditions and is expected to be completed by mid-January 2024. In conjunction with this Share Acquisition, SYLA today has also entered into a "Basic Agreement on Business Alliance" with RIBERESUTE. The Agreement provides that both companies shall negotiate towards entering into a business alliance agreement with respect to the business or operations of both companies, including the purchase and sale of properties, marketing, and the planning and development of new products. The agreement also provides that RIBERESUTE shall not, without the prior written consent of SYLA, do any of the following acts until March 31, 2024: Enter into a capital alliance with third parties; Introduce existing shareholders to third parties or otherwise facilitate the purchase of shares of RIBERESUTE Group companies by third parties. RIBERESUTE operates in the development and sales of family condominiums primarily concentrated in the southern Kanto region. RIBERESUTE has strategically established its core operations around the development and construction of condominium properties, positioning itself as a manufacturing company leveraging its creative strengths and low-cost business model. In contrast, SYLA operates a prop-tech business centered around the "Rimawari-kun" asset management platform and the development of "Rimawari-kun AI" with the mission to democratize real estate investment around the world. The Company is confident that this strategic business alliance would empower both companies to leverage their distinct strengths and expertise, complement and enhance each other's business models, and create business synergies. SYLA believes that, through such a business alliance, both companies should aim to forge new growth strategies in the real estate market, elevate their corporate value, and make significant contributions to solving social issues by actively leveraging their combined management resources. In order to promote a business alliance with RIBERESUTE and strengthen the relationship and trust between the two companies, SYLA has agreed with Jun Planning Co., Ltd., which is the "largest shareholder" and "other related company" of RIBERESUTE and is controlled by Junji Kawai, the founder and former CEO of RIBERESUTE, and certain of his relatives, as well as Mr. Kawai and certain of his relatives to acquire in mid-January 2024 an aggregate of 2,158,800 common shares that the Sellers hold.
|
ZKIN | Hot Stocks09:04 EST ZK International Group granted temporary exception by NASDAQ Hearings Panel - ZK International Group announce that the Nasdaq Hearings Panel has granted the company a temporary exception, enabling it to regain compliance with The Nasdaq Stock Market's. ZK International Group has represented to Nasdaq a comprehensive plan to restore compliance with the Bid Price Rule. The company will effect a reverse stock split, if necessary, to regain compliance by January 19, 2024 and described the actions it intends to take to be able to meet that timeline. The temporary exception extends until January 31, 2024, giving ZK International Group Co., Ltd. a clear timeline to meet these compliance milestones. ZK International Group shall effect a reverse stock split by January 5, 2024 and shall have demonstrated compliance with the Bid Price Rule, by evidencing a closing bid price of $1 or more per share for a minimum of ten consecutive trading sessions, by January 19, 2024.
|
ENVA | Hot Stocks09:03 EST Enova International reaches agreement with CFPB on loan processing errors - Enova International announced that it has reached an agreement with the Consumer Financial Protection Bureau regarding consumer loan processing issues that arose from unintentional technical systems and processing errors which have since been addressed. The majority of items were self-reported by Enova to the CFPB and Enova provided appropriate redress to impacted customers. Enova has agreed to pay a $15M civil money penalty. The settlement is not expected to have a material impact on the company or its operations.
|
RTX | Hot Stocks09:02 EST RTX awarded $870M long-term TF33 engine sustainment contract - Pratt & Whitney, an RTX business, was awarded a long-term TF33 engine sustainment contract valued up to $870M by the Defense Logistics Agency. The TF33 engine powers a range of aircraft, including Boeing's B-52 Stratofortress and E-3 Sentry. Representatives from the Defense Logistics Agency (DLA), the U.S. Air Force and Pratt & Whitney attended a signing ceremony where Tracy Ruland, contracting officer for DLA Aviation, and Chris Johnson, vice president of Fighter & Mobility Programs for Pratt & Whitney, signed a long-term holistic sustainment solution for TF33 engines powering B-52 and E-3 aircraft. This agreement is a culmination of the Defense Logistics Agency's decades-long partnership with the 448th Supply Chain Management Wing, Tinker Air Force Base, Okla., and Pratt & Whitney to establish a holistic sustainment solution. Under this contract, Pratt & Whitney will provide comprehensive engine sustainment services for a global fleet of nearly 1,000 engines over a six-year period, with an option of extending for another four years. Services under this contract include maintenance, spare parts, program management, field service, repairs and engineering support. Sustainment work will run through April 2034 at Tinker Air Force Base, Okla., additional U.S. Air Force locations, and Pratt & Whitney's Southern Logistics Center located in Atlanta, Ga.
|
PMBHF FLHLF | Hot Stocks08:56 EST PharmAla, Filament release second batch of GMP MDMA capsules - PharmAla Biotech and Filament Health announced the GMP release of a second batch of MDMA capsules encapsulated at Filament's Metro Vancouver facility. In addition to the manufacture of GMP LaNeo MDMA Capsules, PharmAla is pleased to report on the execution of two exports by Filament, fulfilling contracts with Emyria and Monash University. The majority of the capsules manufactured in this Batch will be utilized in the Health Canada Special Access Program, as well as fulfillment of clinical trials in a variety of jurisdictions.
|
SUAC | Hot Stocks08:54 EST ShoulderUp Technology Acquisition postpones special meeting of stockholders - ShoulderUp Technology Acquisition Corp. announced that its special meeting of stockholders will be postponed from its scheduled time of 4:30 p.m. Eastern Time on November 15, 2023 to 12:30 p.m. Eastern Time on November 17, 2023. The Special Meeting can still be accessed virtually by visiting https://www.cstproxy.com/shoulderupacquisition/ext2023. You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting. The record date for the Special Meeting remains October 13, 2023.
|
CNSP | Hot Stocks08:51 EST CNS Pharmaceuticals expects cash to fund operations through 4Q23 - As of September 30, 2023, the Company had cash of approximately $0.9 million. In addition, in October 2023, the Company raised an additional $2.6 million in a warrant inducement transaction and placements on the ATM facility. The Company's current expectation is that the cash on hand and cash raised in October is sufficient to fund our operations through the end of the fourth quarter of 2023. The timing and costs of clinical trials are difficult to predict and trial plans may change in response to evolving circumstances and as such the foregoing estimates may prove to be inaccurate.
|
CNSP | Hot Stocks08:50 EST CNS Pharmaceuticals announces upcoming milestones - Report topline results of interim analysis expected in December 2023. Enrollment will continue during the interim analysis. Complete enrollment in December 2023.
|
CNDT | Hot Stocks08:49 EST Conduent implements new contactless payment system in Marseille, France - Conduent Transportation announced that it, along with partners Visa and Caisse d'Epargne CEPAC, are implementing a contactless open payment system for the Aix-Marseille-Provence Metropole on the Marseille public transport network that includes buses, coaches, trams and a metro railway. Marseille is the second largest city in France, and the Aix-Marseille-Provence Metropole is the country's largest metropole, or urban agglomeration, with a population of over 1.8 million. The new system will allow passengers to pay with contactless debit and credit cards, as well as NFC-enabled digital wallets. Testing of the system took place on selected lines during July, and the system is now gradually being rolled out network-wide.
|
LPLA | Hot Stocks08:48 EST LPL Financial launches LPL Private Wealth Management - LPL Financial announced the launch of LPL Private Wealth Management, a new advisor affiliation model for advisors focused on serving high-net-worth clients. At LPL, Private Wealth advisors enjoy the benefits of industry-leading payouts, client ownership and business autonomy while gaining access to enhanced service, expanded capabilities and an exclusive high-net-worth advisor community.
|
XIACY | Hot Stocks08:47 EST Xiaomi, Ambiq collaborate on Xiaomi Smart Band 8 - Ambiq together with Xiaomi collaborated again on Xiaomi Smart Band 8, a new smart band to assist consumers in defining their unique style. The Xiaomi Smart Band 8 completely reimagined a band by its looks, features, and functionalities. Enabled by Ambiq's Apollo4 Blue Lite SoC, Xiaomi Smart Band Xiaomi Smart Band 8 is equipped with all-day SpO2 and heart rate monitoring, sleep monitoring, pressure monitoring, and even female menstrual cycle1. With 200+ pre-set watch faces, Xiaomi Smart Band 8 offers an upgraded appearance, includes a racetrack-shaped 1.62" crystal clear high-resolution AMOLED display, and its upgraded 190mAh battery provides up to 16 days of typical usage on a single charge. The device features 150+ sports modes, providing users with a wide selection of fitness activities to choose from.
|
CDXC | Hot Stocks08:46 EST ChromaDex: Study shows Niagen supplementation increases whole blood NAD+ levels - ChromaDex shares results from a phase II clinical study published in the peer-reviewed journal, Movement Disorders, by a team of researchers led by Dr. Hilde Nilsen, University of Oslo, Arkershus University Hospital, Norway. The promising results demonstrate that long-term supplementation with Niagen NR effectively increased whole blood NAD+ levels up to fourfold, improved coordination, and enhanced eye movement while maintaining biomarkers of stable liver and kidney function in Ataxia Telangiectasia patients. AT is a rare, inherited neurodegenerative disorder characterized by premature aging, cerebellar degeneration, immunodeficiency, and cancer predisposition...This two year phase II clinical study was a single-arm open-label intervention trial investigating the safety and efficacy of long-term NR supplementation in 10 patients with AT ,6 were female, 4 were male, of which 7 were children, 3 were adults, between the ages of 3 to 27 years. The patients were given oral NR as an intervention starting with an initial dose of 150 mg/day, gradually increasing to 300 mg/day, and reaching a final dose of 500 mg/day...Reaching a milestone in NR clinical research as the longest published clinical study to date, results of this study demonstrate that NR effectively increased whole blood NAD+ levels up to fourfold, improved coordination, and enhanced eye movement in both adults and children with AT, while maintaining biomarkers of stable liver and kidney function. The outcomes of this study strongly support the inclusion of NR supplementation as a standard clinical approach for AT, however more research needs to be conducted to confirm the impact of NR on motor skills such as standing and walking.
|
EXLS | Hot Stocks08:44 EST ExlService becomes Premier Level Partner for Google Cloud - EXL is now a Premier Level Partner for Google Cloud in the Service Engagement Model. As a Premier Partner for Google Cloud in the Service Engagement Model, EXL demonstrated its proficiency in leveraging Google Cloud's powerful infrastructure and advanced analytics tools to drive transformative insights for clients. This status underscores EXL's dedication to delivering exceptional value and innovative data-led analytics and AI services.
|
BNXAF | Hot Stocks08:43 EST Banxa Holdings closes second tranche of convertible debenture financing - Banxa Holdings announced that further to its news release dated October 10, 2023, it has raised gross proceeds of C$3.79M under the second tranche of its non-brokered private placement through the sale of convertible debenture units of the Company comprised of unsecured convertible debentures of the Company in the principal amount of C$3.79M and 1,897,013 common share purchase warrants in the capital of the Company. Each Warrant is exercisable into one common share in the capital of the Company at an exercise price of C$1.00 for a period of 36 months from the date of issuance. Banxa has raised C$5.54M to date in aggregate proceeds between the first and second tranche of its Private Placement. Please see the Company's news release dated October 10, 2023 for additional details regarding the terms of the Private Placement. Closing of additional tranches of the Private Placement remain subject to acceptance by the TSX Venture Exchange. The proceeds from the Private Placement are intended to be used to repay senior secured debt of the Company and for general working capital purposes. All securities issued pursuant to the Private Placement are and will be subject to a four month hold period from the date of issue. TIGA Trading participated in the amounts of C$2,000,000 in the second tranche of the Private Placement. TIGA partially funded the C$2,000,000 amount by rolling in its A$2M debt facility, which has been terminated as of October 29, 2023, into this Note. Furthermore, HB Super Holdings Pty Ltd. participated in the amounts of C$379,699 by rolling in its previous debt facility, which has been terminated as of November 2, 2023. Banxa paid cash $57k finders fee and will issue $28.5k in Warrants to Architect Partners.
|
VUZI | Hot Stocks08:41 EST Vuzix and Quanta Computer announce partnership agreement - Vuzix and Quanta Computer, a leading worldwide Original Design Manufacturer, or ODM, announced that the two firms have entered into a partnership agreement which will support the manufacture of next generation lightweight smart glasses for the broader markets. Vuzix is set to shortly deliver the first batch of its latest advanced waveguide and optical display components for this project, and a plan is being put in place for subsequent deliveries to be made throughout 2024. Quanta and Vuzix are committed to presenting innovative smart glasses solutions for the broader markets, making it accessible to a wide range of interested market participants.
|
AREC | Hot Stocks08:41 EST American Resources' ReElement enters JV partnership with JHUT - American Resources Corporation's ReElement Technologies Corporation has entered into joint venture partnership with JHUT LLC to a establish ReElement Technology Japan, an entity that will operate lithium-ion battery and battery material recycling hub in the Oimachi, Oi-gun, Fukui Prefecture of Japan utilizing ReElement's revolutionary and proven critical mineral recycling and refining technology. RTJ will initially build a pilot facility that will operate at the selected site hub in the Oi-machi, Oi-gun, Fukui Prefecture of Japan which is capable of producing 100kg per day of battery grade lithium hydroxide or carbonate to showcase to the Company's partners and customers in the Japanese market. Post commencement of production of the Japanese pilot facility, RTJ will work to increase the scale of the facility through its modular design capability, thereby increasing the Company's capacity to recycle and refine a higher volume of battery material feedstock that is present in the Japanese market. ReElement is currently in the design and buildout phase of its 50 metric ton per day of lithium carbonate/hydroxide production line at their previously announced Marion, Indiana facility, which will be representative of the commercial scale production line that will be developed in Japan post pilot production. ReElement Technologies will receive upfront fees to service, engineer, and design the initial production trains, as well as receive additional ongoing capital from JHUT and affiliates to build the initial commercial qualification plant that will showcase the technology in Japan for commercial partnerships and customers. Post the completion of the initial facility, expected in the second half of 2024, the parties will work together and with other strategic parties to build the first of several expected full-scale commercial facilities within Japan.
|
MCIOF | Hot Stocks08:40 EST HEALWELL AI to acquire majority ownership position in Pentavere Research - HEALWELL AI announces it has entered into an agreement to acquire a majority ownership position in Pentavere Research Group, an AI health-tech company based in Toronto, Ontario, that focuses on identifying eligible patients for approved medications and interventions. Pentavere has a proven track record in commercialization of real-world evidence studies and has developed strong partnerships with major hospital networks. Pentavere's expertise in data abstraction and structuring, combined with their extensive network and experience in hospital specialist care, perfectly aligns with HEALWELL's commitment to improving preventative care. Dr. Alexander Dobranowski, CEO of HEALWELL commented, "We are thrilled at the prospect of welcoming Pentavere, a real AI powerhouse, to the HEALWELL family. This proposed acquisition will represent a major leap forward in our mission to revolutionize healthcare through the use of AI and data science. Pentavere is most certainly one of the leading technology assets in Healthcare AI in Canada. Its advanced DARWEN(TM) platform leverages artificial intelligence and large language models to process complex, unstructured clinical data into easily searchable and referenceable structured data, addressing a critical need in modern healthcare technology. Pentavere has established vital partnerships and secured data-access agreements with major hospital networks in Canada and the United States, solidifying its position as a leader in the industry."
|
MOND | Hot Stocks08:39 EST Mondee acquires Silicon Valley based AI firm Purplegrid, terms undisclosed - Mondee Holdings has announced its acquisition of Purplegrids, a Silicon Valley based, cutting-edge AI company founded in 2017. This acquisition strengthens Mondee's tech capabilities and showcases its commitment to vertically integrate AI across travel. Mondee has been actively developing and implementing its next-generation AI platform, including the launch of Abhi, the only fully integrated solution in the travel market, encompassing conversational and expert-trained generative AI curated experiences, real-time travel booking and itinerary management. Mondee completed the acquisition on November 13th, in an all-share transaction, further strengthening its leadership in travel AI and widening Mondee's first-mover advantage. Purplegrids' innovative Enterprise AI platform uniquely integrates the advantages of Generative AI with private LLMs, Deep Learning and Computer Vision with diverse data sources, seamlessly blending them with native enterprise integration and business intelligence capabilities on a no-code/low-code framework for building next generation AI apps.
|
YTEN | Hot Stocks08:38 EST Yield10 announces USDA-APHIS's BRS determined Camelina can be grown in US - Yield10 Bioscience announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service's, USDA-APHIS's, Biotechnology Regulatory Services, BRS, has determined that Yield10's stacked herbicide tolerant Camelina sativa may be grown and bred in the United States. In April 2023, Yield10 submitted Request for Confirmation of Regulatory Status packages to the BRS under the Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient Rule, for stacked HT Camelina varieties. The response from USDA-APHIS means that the agency does not consider the modified Camelina varieties to be an increased plant pest risk as compared to unmodified Camelina] and are therefore not subject to regulation under 7 CFR part 340 regulations. "Our team has done outstanding work advancing the development and commercialization of HT and stacked HT Camelina," said Oliver Peoples, Ph.D., Chief Executive Officer of Yield10 Bioscience. "We expect these varieties to form the centerpiece of our portfolio of elite Camelina varieties that our team will be able to offer to growers and will be critical to enabling the cultivation of Camelina on large acreage in North America. Our commercial strategy is to advance our leadership position in Camelina by innovating to bring forward new value-added traits to the Camelina crop that provide meaningful improvements in yield, agronomic, and economic performance to the grower."
|
DECPF | Hot Stocks08:38 EST Diversified Energy reports Q3 average net daily production 804 MMcfepd - Commenting on the results, CEO Rusty Hutson, Jr. said: "We have once again delivered consistent and reliable results during the third quarter despite continued commodity price headwinds. Our solid operational execution against the high-quality assets we manage, the ongoing integration of our most recent acquisitions of Tanos II and ConocoPhillips, and our focus on efficiency delivered sequential cost improvement, which translated into 52% Adjusted EBITDA margins. The asset performance and stability of cash flows were further corroborated by Fitch's recent affirmation of its ABS notes rating. The combination of peer-leading, low capital intensity, and low corporate declines creates a distinct competitive advantage for our Company, mitigating the need to replace production while maintaining free cash flow generation from an asset base that provides consistent production. Implementing our smarter asset management programs enhances the discretionary cash flow we generate and increases the availability of capital for reinvestment, debt repayment, and return of capital to shareholders, ultimately creating long-term value. I am also incredibly proud of the ongoing focus on sustainability, with our achievements being rewarded by a distinguished panel of European judges bestowing our 2022 report, "Decarbonizing While Delivering," with the ESG Report of the Year, recognizing it as the most accurate, best structured and informative report. Our commitment to providing long-term total returns to shareholders is underscored by our consistent dividend history, declaring our 25th consecutive dividend, returning over $800 million of capital to shareholders, including share repurchases, since going public in 2017. The management team and Board remain focused on executing value-enhancing initiatives to drive additional returns for our shareholders."
|
AENT | Hot Stocks08:37 EST Alliance Entertainment's Mill Creek announce pre-sales for THE BLIND - Mill Creek Entertainment, a division of Alliance Entertainment Holding Corporation, announced another successful Home Entertainment release with THE BLIND. In partnership with Pinnacle Peak Pictures and Tread Lively, THE BLIND recently hit #1 in pre-sales on Amazon during its first weekend across all movies & TV, edging out strong competition from Hollywood studio box office hits BARBIE, SOUND OF FREEDOM and OPPENHEIMER. It is currently #1 in overall DVD sales and #1 in Faith/Spirituality. THE BLIND grossed over $17 million in box office sales since its theatrical release on September 28, 2023, becoming Fathom Events' highest-grossing release of all time.
|
MAXN | Hot Stocks08:37 EST Maxeon subsidiary files patent infringement lawsuit against Shanghai Aiko - Maxeon Solar Technologies announced that its subsidiary Maxeon Solar Pte. filed patent infringement lawsuits against Shanghai Aiko Solar Energy, its subsidiaries Aiko Energy Germany and Solarlab Aiko Europe, and its wholesaler Memodo in Mannheim District Court, Germany. The lawsuit against Aiko and Memodo alleges infringement of Maxeon's European Patent No. EP2297788B1, or "Back-contacted solar cells with doped polysilicon regions separated via trench structures and fabrication process therefor". This patent relates to proprietary and fundamental solar cell architectures for rear or back contact solar cells, also known as All-Back Contact, or ABC, solar cells or Interdigitated Back Contact, or IBC, solar cells. Back contact solar cells, such as Maxeon IBC solar cells, are distinct from conventional front contact solar cells, which have metal contacts on the front surface. Front surface metal contacts block sunlight and reduce efficiency.
|
PMCB FEMY | Hot Stocks08:37 EST PharmaCyte Biotech makes $5M investment in Femasys to utilize cash position - PharmaCyte Biotech (PMCB) announces it has made a $5M investment in Femasys (FEMY) ...Femasys offers a broad portfolio of in-office, accessible solutions, including a lead late-stage product candidate and innovative therapeutic and diagnostic products. This is the Company's first investment in externally developed technology, which it believes will provide significant additional shareholder value and serve as a prudent use for its approximately $74.6M cash position as of July 31 which was previously reported in the Company's Quarterly Report on Form 10-Q filed on September 18. As part of the agreement, PharmaCyte's interim CEO Josh Silverman will join the Femasys' Board of Directors. "The stake we have taken in Femasys is the beginning of an expansion of our corporate strategy that seeks to identify opportunities outside of our own drug development activities where we can create value both through cash investment and our own expertise. Femasys has an impressive track record in product development and commercialization, and its offerings address significant unmet medical needs in the women's health arena. We believe we can contribute to its continued development and look forward to further collaboration and sharing in Femasys' success. Further, we will continue to seek out opportunities where the strategic deployment of cash will ultimately result in additional value for PharmaCyte and its shareholders," said Mr. Silverman.
|
HSON | Hot Stocks08:36 EST Hudson RPO appoints Jake Zabkowicz as global CEO - Hudson RPO, a global total talent solutions company owned by Hudson Global, announced the appointment of Jacob "Jake" Zabkowicz as Global CEO, effective November 15, 2023. As Global CEO for Hudson RPO, Mr. Zabkowicz will lead the vision, strategy, and execution of Hudson RPO's growth plan. Jeff Eberwein will remain CEO of Hudson Global, Inc. and will continue to focus on capital allocation, acquisitions, corporate strategy, and maximizing shareholder value. Zabkowicz, most recently was Senior Vice President, Global RPO at Korn Ferry.
|
DDD | Hot Stocks08:35 EST 3D Systems receives FDA clearance for NextDent base - 3D Systems announced the Food and Drug Administration, FDA, has provided 510(k) clearance for its NextDent Base material that is intended for the manufacturing of denture bases to support artificial teeth to form full or partial removable dentures. This material is approved by Health Canada and also received CE marking 1639. NextDent Base is the third generation of the company's denture base material for 3D printing and has excellent mechanical properties including high break resistance, and accurate and repeatable printability. "Our goal is to ensure we are addressing our customers' needs with our solutions, and this is yet another step in achieving that goal," said Chuck Stapleton, vice president and general manager, dental, 3D Systems. "With the clearance of NextDent Base, we continue to add to our portfolio of dental 3D printing materials that are enabling dental laboratories and clinics to address a wide range of applications. These offerings are helping our customers accelerate the adoption of additive manufacturing as part of their workflows and drive new levels of speed, productivity, efficiency, and precision while also providing opportunities to improve the patient experience."
|
KNDI | Hot Stocks08:34 EST Kandi Technologies to launch 500 fully electric mini golf carts in the U.S. - Kandi Technologies Group announced that its first batch of 500 all-electric mini golf carts has arrived in the United States and will be gradually released in the market starting this month. Designed by American professionals, the carts were meticulously developed and manufactured by Kandi. Among other features, these models boast electric telescopic functionality, enhancing convenience for travel and portability. These golf carts are not only compact, versatile, and practical but also showcase a distinctive exterior design, all offered at a reasonable price. Kandi is confident that the electric mini golf carts will be favored by consumers and become another popular product of the Company.
|
TGT | Hot Stocks08:34 EST Target sees FY23 CapEx at high end of guidance range - Sees FY24 CapEx "somewhat lower" than FY23, in the $3B-$4B range.
|
HMBL | Hot Stocks08:33 EST HUMBL launches AFL League website - HUMBL announced the launch of the new Arena Football League website. The new AFL League website is "Powered by HUMBL," and will offer a variety of ways to interact with the league, its athletes, teams, partners and fans throughout the season. The new AFL League website features information about the league, its mission, teams, partners, staff, social media and more. The AFL League website will also serve as a home for season ticket deposits, regular season and playoff tickets, as well as fan experiences, in addition to the AFL Mobile application. The AFL Shop is also delivered by HUMBL Authentics and features hats, hoodies, t-shirts and more with the iconic AFL logo. Further team jersey and sideline collections will be offered as well through additional AFL merchandise partners.
|
KZIA | Hot Stocks08:33 EST Kazia Therapeutics to release PNOC022 clinical study abstract - Kazia Therapeutics announced that the Society of Neuro-Oncology 2023 Annual Meeting late breaking abstract entitled "PNOC022: a combination therapy trial using an adaptive platform design for patients with diffuse midline gliomas, or DMGs, at initial diagnosis, post-radiation therapy and at time of therapy" was released by the conference organizers on 10 November 2023. The preliminary results from a single cohort in this Pacific Pediatric Neuro-Oncology Consortium, or PNOC, sponsored cooperative group clinical study will be presented on Sunday, 19 November 2023 in Vancouver, Canada. Sixty-eight children and young adults with DMG who completed standard of care radiation treatment received paxalisib and ONC201. The abstract reported that median overall survival from time of diagnosis was 16.5 months. Key Points from the Abstract include: 68 patients with biopsy-proven DMG were enrolled between November 2021 and June 2023; Median OS from time of diagnosis was 16.5 months with a median follow-up time of 9.9 months; most common grade 3 and above treatment-related adverse events were decreased neutrophil count; mucositis; and, colitis, drug reaction with eosinophilia and systemic symptoms, decreased lymphocyte count, hyperglycemia, and hypokalemia.
|
PAVS | Hot Stocks08:32 EST Paranovus signs software development agreement with BlueLine Studios - Paranovus Entertainment announced that it has entered into a software development agreement with BlueLine Studios, a portfolio company of Caravan Digital, a co-founder of consumer companies authentically powered by iconic artists and athletes in partnership with Creative Artists Agency, to focus on developing the AI-generated content game application, Hollywood Sunshine. Under the terms of the agreement, BlueLine will be committed to the development of the "Hollywood Sunshine" project, which is expected to be a unique social gaming platform that has celebrity involvement and is driven by AIGC. The project will be an engaging story-based role-playing game in an open world, available on both PC and/or mobile platforms. The game aims to captivate users with real-time, instantaneous player-specific content generation, offering many hours of narrative-driven gameplay. BlueLine and Caravan will be working together to secure an appropriate celebrity talent partner for the game, who should demonstrate receptiveness to working with AIGC and have a fanbase reach of at least 5M individuals. Paranovus will pay BlueLine a total of up to $1.9M development fee and subject to the terms of the agreement, Paranovus will be the sole and exclusive owner of all rights to the Hollywood Sunshine project, including all intellectual property rights, excluding any background technology used by BlueLine to complete the project. An initial full-featured version of the game for the PC platform is anticipated to be released in Q2 2024, followed by the potential delivery of the iOS version in Q3 2024.
|
SAR | Hot Stocks08:32 EST Saratoga Investment increases quarterly dividend 1.4% to 72c per share - Saratoga Investment announced that its Board of Directors has declared a quarterly dividend of $0.72 per share for the fiscal third quarter ended November 30, 2023, an increase of $0.01 from $0.71 per share in the prior fiscal second quarter, and the fifteenth quarterly dividend increase in a row. This dividend is payable on December 28, 2023, to all stockholders of record at the close of business on December 11, 2023
|
VEON | Hot Stocks08:26 EST VEON, Summit reach $100M deal for partial sale of Bangladesh tower portfolio - VEON announces that its wholly owned subsidiary Banglalink has entered into an agreement to sell part of its tower portfolio in Bangladesh to Summit Towers Limited for BDT 11 billion - equivalent of roughly $100M. The deal includes a long-term service partnership with Summit Towers. Upon closing of the deal, more than 2,000 towers - about one-third of Banglalink's towers portfolio - will be transferred to Summit Towers, a company majority-owned by Summit Communications Group, a leading Bangladeshi infrastructure group. The closing of the transaction is subject to regulatory approvals from the Bangladesh Telecommunication Regulatory Commission. The proceeds from the sale will primarily be used to service Banglalink's financial commitments, and for generating cost efficiencies while freeing up resources for the company's digital expansion.
|
TGT | Hot Stocks08:24 EST Target maintaining cautious inventory posture in planning for Q4
|
ZTEK | Hot Stocks08:20 EST Zentek reports expansion of aptamer-based platform technology - Zentek announces the development of a significant upgrade to its aptamer platform improving the binding affinity of the universal Covid-19 aptamer from 300 to over 500 times, compared to the base aptamer. The improved platform has also solved key challenges for manufacturing and these High-Binding Affinity aptamers are now produced with approximately a 95% yield. A key roadblock of translating a promising lead candidate into a commercial product is cost-effective and high-purity manufacturing. Solving production at this early stage of the development program is essential for successful clinical trials and the lower manufacturing costs and high yields should translate into a competitive advantage over many existing therapies. The Company has filed a new provisional patent to protect this latest innovation. As Zentek has been engaged with industry experts regarding the platform innovation, there has been consistent feedback that the greatest potential for the aptamer platform is towards precision therapy which is currently dominated by monoclonal antibodies. Zentek and their partners at McMaster University will be exploring oncology and immunology research. A pharmaceutical industry study by Dr. Wouters from the London School of Economics and Political Science calculated that between 2009-2018, the cost for a new potential therapeutic to complete pre-clinical trials was $237M USD without factoring any costs resulting from drug failure. The Zentek HBA aptamer for SARS-CoV-2 has demonstrated strong therapeutic potential through four different animal tests and is at the current stage of development for a total cost of less than $2,000,000. Zentek estimates that an additional $1.0 million will be required to complete the pre-clinical program for the SARS-CoV-2 therapeutic and enter clinical trials. Zentek believes these significant cost and timeline advantages are inherent to the Aptamer Platform technology and will be transferable to other aptamer-based medicines. In addition, increased binding affinity, greater bioavailability without the need for polyethylene glycol and high-yield manufacturing of HBA aptamers may lead to therapeutics with performances that are comparable to or outperforming their monoclonal antibody counterparts. There are already many aptamer-based therapies in development globally and Zentek's platform technology could potentially be a plug and play addition to these that could improve their performance.
|
CLSH | Hot Stocks08:19 EST CLS Holdings enters licensing agreement to expand into New Mexico - CLS Holdings USA announced its expansion into the New Mexico market via a strategic Licensing Agreement. CLS owns Serenity Wellness Products LLC, a licensed Nevada company, which does business as City Trees. Through this Licensing Agreement, City Trees is thrilled to now be in the thriving New Mexico market. This market expansion will mark the first time that City Trees cannabis vapes will be available outside of the Nevada market. This move marks a significant milestone for City Trees, solidifying its commitment to providing high-quality cannabis vape products to consumers at a low cost across different states. The Company's decision to enter the New Mexico market is a testament to the region's growing demand for innovative and premium cannabis products. The Licensing Agreement, entered into with a state-of-the-art facility in New Mexico, enables City Trees to scale its production capabilities and meet the increasing demand for its popular vape products. Leveraging the expertise and resources of its manufacturing partner, including a distribution channel of over 500 dispensaries in New Mexico, the Company aims to ensure a seamless transition into the New Mexico market while maintaining its unwavering commitment to product quality, safety, and compliance.
|
ATHA | Hot Stocks08:17 EST Athira Pharma presents preclinical data on fosgonimeton - Athira Pharma presented new preclinical data supporting the potential therapeutic benefit of fosgonimeton for the treatment of Alzheimer's disease and other neurodegenerative diseases at the Society for Neuroscience Annual Meeting 2023, being held in Washington, D.C. from November 11 - 15, 2023. Oral Presentation Fosgonimeton, a Small-Molecule Positive Modulator of the Neurotrophic HGF System, Protects Against Amyloid beta-induced Pathological Alterations in Alzheimer's Disease Models In Vitro and In Vivo. Sharay Setti, Ph.D., Senior Scientist, Athira Pharma, presented preclinical findings demonstrating fosgonimeton's neurotrophic and neuroprotective activity in Abeta models of AD. In vitro, the active metabolite of fosgonimeton reduced Abeta-induced neurite degeneration, tau phosphorylation, mitochondrial stress, and neuronal death. In an Abeta mouse model of AD, fosgonimeton improved cognitive performance in both Y-maze and Morris water maze trials, protected hippocampal neurons from degeneration, and promoted cell proliferation in the subgranular zone, showing potential to support adult neurogenesis. Poster Presentation: Fosgonimeton, a small-molecule positive modulator of the neurotrophic hepatocyte growth factor system, inhibits LPS-mediated neuroinflammation in BV2 microglia. Wei Wu, Ph.D., Senior Scientist II, Athira Pharma, presented preclinical research demonstrating the cellular mechanisms by which fosgonimeton induces anti-inflammatory effects in BV2 microglia cells. In vitro, the active metabolite of fosgonimeton inhibited the expression of pro-inflammatory mediators, reduced mitochondrial dysfunction, and decreased oxidative stress in LPS-stimulated microglia. The anti-inflammatory effects of fosgonimeton demonstrated in these models suggest it may have the potential to help reduce neuroinflammation, a key pathological feature of several neurodegenerative diseases.
|
MCHP | Hot Stocks08:15 EST Microchip launches latest TrustAnchor Security IC TA101 - As vehicles become more connected and technologically advanced, the need for heightened security measures also rises. New government and automotive OEM cybersecurity requirements are beginning to include larger key sizes and Edwards Curve ed25519 algorithm standards. In response, Microchip Technology has launched its latest TrustAnchor Security IC, the TA101, which can accommodate complex automotive and embedded security use cases. The TA101 supports large key sizes up to ECC P521, SHA512, RSA-4K and AES256 with greater security strength, exceeding current standards and allowing room for future adjustments while maintaining backwards compatibility for smaller keys. The TA101 is offered as an industrial-grade CryptoAuthentication Security IC and as a CryptoAutomotive Security IC supporting AEC-Q100 Grade 1 qualified devices.
|
ACI | Hot Stocks08:15 EST Healthpilot announces partnership with Albertsons - Healthpilot announced its partnership with Albertsons Companies. Through this collaboration, Albertsons customers will gain access to Healthpilot's AI-powered platform, allowing them to explore a range of Medicare plans from major insurance carriers. Healthpilot's intelligent algorithms analyze each customers' needs and preferences, offering personalized recommendations tailored to customers' own healthcare needs. This partnership aims to provide accessible and convenient access to finding the optimal Medicare plan, allowing customers to make informed decisions about their coverage.
|
GRI | Hot Stocks08:15 EST GRI Bio reports net less $11M for nine months ended September 30 - As of September 30, 2023, the Company had cash and cash equivalents of approximately $3.5 million. Expected GRI-0803 Upcoming Milestones: H1 2024: Complete IND-enabling studies; H1 2024: File IND and launch Phase 1a/b; Q3 2024: Report Phase 1a SAD topline results; Q4 2024: Report Phase 1b MAD topline results. "Over the course of this year, we have made fundamental progress on the development and regulatory fronts for our lead program GRI-0621 for IPF as well as GRI-083 for SLE. Importantly, we believe 2024 will be the year of data for GRI Bio," commented Marc Hertz, PhD, Chief Executive Officer of GRI Bio. "We believe we are positioning ourselves for a transformational year and have the potential to unlock significant value for all stakeholders."
|
NNWWF | Hot Stocks08:14 EST North West Company announces renewal of normal course issuer bid - The North West Company announced that the Toronto Stock Exchange has accepted notice of the Company's intention to make a normal course issuer bid for a portion of its common voting shares and variable voting shares as appropriate opportunities arise from time to time. The board of directors of the Company believes that the purchase by the Company of a portion of its outstanding Shares may from time to time be an appropriate use of available resources and in the best interests of the Company. Pursuant to the NCIB notice filed with the TSX, the Company may acquire up to a maximum of 4,733,380 of its Shares, or approximately 10% of its public float as of the date of November 9, 2023, for cancellation over the next 12 months. As of November 9, 2023, the Company had 47,689,226 issued and outstanding Shares. Purchases under the NCIB will be made through the facilities of the TSX or through Canadian alternative trading systems and in accordance with applicable regulatory requirements at a price per Share equal to the market price at the time of acquisition. The number of Shares that can be purchased pursuant to the NCIB is subject to a current daily maximum of 33,239 Shares, subject to the Company's ability to make one block purchase of Shares per calendar week that exceeds such limits. In connection with the NCIB, the Company has established an automatic securities purchase plan with its designated broker to facilitate the purchase of Shares under the NCIB at times when the Company would ordinarily not be permitted to purchase its Shares due to regulatory restrictions or self-imposed blackout periods. Under the Plan, before entering a self-imposed blackout period, North West may, but is not required to, ask the designated broker to make purchases under the NCIB within specified parameters. Outside of the pre-determined blackout periods, Shares may be purchased under the NCIB based on the discretion of the Company's management, in compliance with TSX rules and applicable securities laws. The Company may elect to suspend or discontinue its NCIB at any time. The automatic securities purchase plan will be effective as of November 17, 2023. All Shares purchased under the NCIB will be cancelled upon their purchase. The Company intends to fund the purchases out of its available resources. The Company may begin to purchase Shares on November 17, 2023 and the NCIB will terminate on November 16, 2024, or such earlier date as the Company completes its purchases pursuant to the NCIB or provides notice of termination. The NCIB follows the Company's normal course issuer bid for the 12 months ended November 14, 2023. Under the 2023 NCIB, the Company had obtained approval to purchase up to 4,740,895 Shares. The 2023 NCIB began on November 15, 2022 and ended on November 14, 2023. Within the past 12 months, under the 2023 NCIB the Company repurchased through the facilities of the TSX and alternative Canadian trading systems, and cancelled, 153,998 Shares at a weighted average purchase price of $32.47 per Share as at October 31, 2023.
|
BURU | Hot Stocks08:14 EST Nuburu awarded purchase order from major multinational electronics manufacturer - Nuburu announced it has been awarded a purchase order from a best in class, multinational electronics manufacturer with manufacturing capabilities across Asia, Latin America, Europe and the U.S., to supply a BL-250 for next-generation computers, consumer electronics and communication 3C device manufacturing. NUBURU's transformational blue laser technology will be utilized in a research and development capacity to demonstrate the integration of its laser welding capabilities as an alternative to conventional soldering manufacturing techniques.
|
ALAR | Hot Stocks08:12 EST Alarum announces NetNut granted U.S. patent - Alarum Technologies has announced that its wholly owned subsidiary, NetNut, was granted United States Patent No. 11,818,104 for its groundbreaking innovation, titled ANONYMOUS PROXYING. This patent, officially granted on November 14, 2023, signifies a significant milestone in the Company's commitment to advancing technology and delivering cutting-edge solutions to its customers. The newly granted patent describes a method, which brings a novel twist to traditional proxy services. Unlike conventional anonymous proxies, where proxy service client requests would be rerouted through an intermediate proxy device, thus potentially slowing down the connection and exposing a device's local network to security risks, NetNut's "reflector" method achieves the same end-result without such detour. It uses the IP address of an intermediate device to initiate the connection, and after this initial step, client requests are sent directly to the target server. "We are proud to receive this patent, which is a testament to our team's hard work and dedication to innovation," said Shachar Daniel, Chief Executive Officer of Alarum. "This new patent expands our intellectual property portfolio and strengthens our position in the market. It also provides us with a competitive edge, ensuring that we can continue to deliver value and maintain our leadership in the internet-access and web-data collection markets."
|
CODI FOXF | Hot Stocks08:12 EST Compass Diversified completes sale of Marucci Sports to Fox Factory - Compass Diversified (CODI) announced completion of the sale of its majority owned subsidiary, Wheelhouse Holdings, the parent company of Marucci Sports, LLC, to Fox Factory Holding Corp. (FOXF). The sale price was based on an enterprise value of $572 million, subject to certain working capital and other adjustments. After these adjustments, as well as for an allocation to Marucci's non-controlling shareholders and the payment of transaction expenses, CODI received approximately $485 million of total proceeds from the sale at closing. This amount was in respect of its debt and equity interests in Marucci and the payment of accrued interest. As previously announced, CODI expects to record a pre-tax gain of approximately $225 million to $245 million from the sale. Net proceeds will be used to pay down outstanding debt and for general corporate purposes.
|
SPRC | Hot Stocks08:11 EST SciSparc announces results from its Phase II trial on SCI-110 - SciSparc unveils positive topline results from its investigator-initiated Phase IIa trial at the Sophie & Abraham Stuchynski Israeli Alzheimer's Medical Center, IMCA. The trial results indicated that SciSparc's proprietary SCI-110 provided a safe and effective solution for alleviating agitation in elderly Alzheimer's patients who participated. SciSparc's open-label Phase IIa trial, conducted at IMCA, encompassed 18 AD patients grappling with agitation. It aimed to assess the safety, tolerability, and effectiveness of SCI-110, administered orally twice daily. The results not only met primary endpoints regarding tolerability and adverse events but also demonstrated SCI-110's potential to alleviate agitation without side effects. Importantly, patients treated with SCI-110 were free of delirium, oversedation, hypotension, or falls, demonstrating its potential safety and suitability for elderly patients. The trial, titled "Phase IIa Open Label Trial to Evaluate the Safety, Tolerability and Efficacy Trend of SCI-110 in Patients with Alzheimer's Disease and Agitation," was conducted at IMCA under the guidance of Dr. Alexander Kaplan, MD, a board-certified geriatrician and principal investigator. This single-arm, open-label trial saw each subject receiving SCI-110 twice daily via oral administration, with follow-up for up to 39 days.
|
AIZ | Hot Stocks08:11 EST Assurant names Keith Meier CFO, Francesca Luthi COO, effective immediately - Assurant announced the realignment of its executive team to support its global growth strategy and sustain business momentum by appointing Keith Meier as chief financial officer and Francesca Luthi as chief operating officer, effective immediately. As chief financial officer or CFO, Keith Meier will have oversight of Assurant's global finance and technology organizations and continue to report to Assurant president and CEO Keith Demmings. Meier started his career at Price Waterhouse LLP , specializing in insurance. During his 25-year tenure at Assurant, he has held leadership roles within several of Assurant's global businesses. As Head of International, he successfully improved the underlying performance of the company's European operations and expanded its global footprint in key markets, including establishing a leadership position in Japan. Most recently, Meier served as chief operating officer during which he integrated the company's operations and technology teams, driving technology innovation to reduce cost-to-serve while enhancing the customer experience for Assurant's major lines of business.
|
TGT | Hot Stocks08:10 EST Target plans to hire nearly 100,000 employees for holiday season, says CEO
|
ASST | Hot Stocks08:10 EST Asset Entities appoints Kyle Fairbanks as CMO - Asset Entities announced, effective November 10, 2023, that Kyle Fairbanks, Board Member and Executive Vice Chairman of Asset Entities, has taken over the role of Chief Marketing Officer for Jackson Fairbanks. With Jackson Fairbanks' significant social media presence, he has been named Director of Socials and will be working with the marketing team.
|
PEPG | Hot Stocks08:10 EST PepGen announces appointment of Mayer to board of directors - PepGen announced the appointment of Howard Mayer, M.D. to the PepGen Board of Directors, effective November 15, 2023. Dr. Mayer was most recently Executive Vice President, Head of Research and Development at Ipsen Pharmaceuticals from 2019 until 2023.
|
ASST | Hot Stocks08:09 EST Asset Entities completes acquisition of Ternary, OptionsSwing, appoints CTO - Asset Entities has acquired all of the assets of Ternary Inc., a cloud-based subscription management solution for Discord communities and Stripe-verified payment processor, and OptionsSwing Inc., an investment research and analysis education service. The acquisitions are intended to add new Discord and social media customers to Asset Entities, expand the Company's platform, and, via Ternary, provide a Stripe-verified, state-of-the-art payment processing SaaS platform to Asset Entities' AE.360.DDM suite of services for Discord communities and beyond. The acquisitions are accretive and add valuable management team members, including Jason Lee, who is the Founder and CEO of both Ternary and OptionsSwing, who was a member of the 2021 Forbes Next 1000 list of leading young entrepreneurs, and was recognized as a Salesforce Alumni, the company's elite group of former employees honored for outstanding professional accomplishments. In connection with the transaction and pursuant to the Asset Purchase Agreement, Asset Entities has acquired all of the assets of Ternary and OptionsSwing which includes, but is not limited to, all customer accounts, intellectual property, software platforms, and revenue streams. Asset Entities has also secured multi-year employment agreements and stock award agreements for Mr. Lee and his team as part of the acquisition. The employees are Mr. Lee; Roberto Infante, a Co-Founder and CTO at Ternary; Janet Hung, a Co-Founder and COO of both Ternary and OptionsSwing; and Daniel Montoya, Head of Sales at Ternary. Mr. Lee assumes the role of CTO for Asset Entities, Janet Hung will become the Company's Director of Customer Relations, Mr. Infante will become a Senior Software Developer, and Mr. Montoya will become a Senior Sales Director. Each of these employees will work to maximize the integration of Ternary and OptionsSwing into Asset Entities.
|
CHR | Hot Stocks08:09 EST Cheer Holding announces CHEERS Telepathy app officially launched - Cheer Holding announced that its multimodal artificial intelligence content creation platform CHEERS Telepathy has officially launched its app and WeChat mini program after completing all relevant regulatory filings and is now fully compliant. Now, users can immerse themselves in CHEERS Telepathy across three platforms: the app, WeChat mini program, and PC.
|
GFF | Hot Stocks08:08 EST Griffon increases share repurchase program by $200M - The board of directors of Griffon authorized the repurchase of an additional $200M worth of shares of Griffon common stock. During the fiscal year ending September 30, Griffon repurchased 4.1M shares of common stock for a total of $150.8M, or an average of $36.39 per share. Total remaining under the share repurchase authorization as of September 30 was $107.2M. During the period October 1 through market close on November 14, Griffon repurchased 1.1M shares of common stock, for a total of $45M or an average of $39.91 per share. As of the market open, including the $200M authorization increase, Griffon has a total of $262M available under its stock repurchase program.
|
GRFS | Hot Stocks08:08 EST Grifols completes cohort 1 in study of Alpha-1 15% - Grifols announced that it has completed Cohort 1 of its Phase 1/2 study evaluating Alpha1-Proteinase Inhibitor Subcutaneous 15%, a subcutaneous alpha antitrypsin treatment being compared to Liquid Alpha1-Proteinase Inhibitor intravenous. In this multi-center, single-dose and repeat-dose study over eight weeks, Cohort 1 has been completed and demonstrated no safety issues with Alpha-1 15% that would prevent the study from moving forward into Cohort 2. "A subcutaneous option would be a first for alpha-1 patients, providing more freedom when it comes to managing their AAT deficiency by allowing patients to administer their medication from the comfort of their own home. We are pleased to announce this milestone during Alpha-1 Awareness Month, contributing to raising further visibility about this rare disease," said Jorg Schuttrumpf, Chief Scientific Innovation Officer, Grifols. "We look forward to moving this study into Cohort 2. Grifols has a strong commitment to the alpha-1 community and continues to innovate to find additional treatment options for patients living with this disease, in addition to more convenient alpha-1 testing alternatives such as AlphaID(TM) At Home, our recently launched direct-to-consumer genetic health risk service."
|
TGT | Hot Stocks08:07 EST Target CEO: Consumers delaying spending until last moment
|
XWEL | Hot Stocks08:07 EST Xwell opens new XpresSpa location in Abu Dhabi International Airport - XWELL announced the grand opening of its 34th wellness center in Abu Dhabi International Airport. The Abu Dhabi XpresSpa marks the brand's 11th international location and adds a valuable extension to the growing UAE traveler base, highlighted by the approximately 52 million passengers that passed through Abu Dhabi International Airport and Dubai International Airport alone in the first six months of 2023. "This is another proud moment for XWELL and XpresSpa as we near the end of a busy 2023," said XWELL CEO Scott Milford. "By continuing to expand our presence internationally, especially in the UAE as it evolves into a major transportation hub, we're demonstrating our commitment to meeting travelers where they are by establishing another vital and convenient place to recharge."
|
EVAX | Hot Stocks08:06 EST Evaxion Biotech presents proof-of-principle for its AI model - Evaxion Biotech presents for the first time its AI model designed to predict patient responses to cancer immunotherapy at the Biomarkers & Precision Oncology Europe conference in Berlin, Germany. "When I joined Evaxion, I was inspired by the wealth of opportunities to improve the lives of patients facing life-threatening diseases. Building upon Evaxion's core competencies, we have developed an AI model that shows promising results in predicting patients at risk of advancing into progressive disease while undergoing checkpoint inhibitor therapy, enabling earlier intervention with alternative treatments," commented Christian Kanstrup, Evaxion's Chief Executive Officer. Christian continued, "We set out to improve patient outcomes and address the growing healthcare burden by developing our first checkpoint inhibitor response predictor model. The model relies on our unique AI-Immunology(TM) platform, builds upon our existing core competencies and is part of the "Responder" leg of our corporate strategy. Today's presentation marks our first step on our journey towards this goal, and we will develop a commercial offering where collaboration and partnerships will be instrumental in achieving our vision for a more cost-effective and efficient healthcare system as well as improving patient outcomes."
|
ACN | Hot Stocks08:05 EST Accenture invests in virtual production firm V Technologies, no terms - Accenture has invested in V Technologies, a technology company specialized in virtual production and filmmaking. V helps companies create immersive, engaging experiences through a combination of real-time computer-generated imagery and live-action filming. V has established a vast network of virtual studios across North America, producing memorable immersive environments and stunning visual effects for companies including Amazon, CBS Sports and Disney. Using advanced technologies such as real-time rendering, motion capture and virtual reality to seamlessly blend live-action footage and computer-generated content, V helps companies visualize and transform creative production at pace and scale. V also uses a proprietary generative AI workflow tool called V.ai that augments pre-built virtual environments and designs workflows based on image and text prompting. "Massive potential exists for companies to combine virtual production and state of the art technologies to create shared, immersive experiences for customers, employees, and other key stakeholders," said David Treat, co-lead of Accenture's Metaverse Continuum business group. "With technologies such as digital twin environment simulation, volumetric video capture and motion control robotics, V's end-to-end capabilities can help our clients create powerful new experiences that attract and engage audiences."
|
FOXF | Hot Stocks08:05 EST Fox Factory completes acquisition of Marucci Sports - Fox Factory announced it has closed its acquisition of Wheelhouse Holdings, the parent company of Marucci Sports, at an enterprise value of $572M. Additional benefits of the transaction include: The deal provides immediate financial benefit - the transaction is expected to be accretive across all key financial performance metrics for FOX, including revenue, EBITDA margin and earnings per share. The significant growth power of the Marucci business. The potential for value-additive synergies. The compounded value of compatible company cultures. Builds on FOX's history of successful diversification through acquisitions. "Our acquisition of Marucci represents a major milestone for FOX as we continue to identify ways to drive synergistic growth without compromising the core identity and values that have been so crucial to our success," said Mike Dennison, FOX's Chief Executive Officer. "This deal is not about baseball. It's about adding a business to our platform that clearly meets our growth criteria, given that each company's individual power to grow and deliver shareholder value will be stronger together. Importantly, Marucci and its team share our commitment to winning through superior innovation and quality products in order to help drive leading positions in each of the key markets where we compete."
|
TGT | Hot Stocks08:04 EST Target remains "cautious" in near-term outlook, says CEO Cornell
|
TGT | Hot Stocks08:04 EST Target has seen meaningful improvement in profitability vs. last year, says CEO - Comments taken from Q3 earnings conference call.
|
LQDT | Hot Stocks08:04 EST State of Alaska sells Steel Patrol Vessel on GovDeals - The State of Alaska is currently offering a 2004 custom-built 74-foot, Steel Patrol Enforcer Vessel on GovDeals. This custom vessel was constructed in 2002 to fulfill the needs of a larger class vessel in the southeastern part of the state. The boat was initially designed to allow law enforcement in the area to patrol and inspect commercial fishing districts. The Enforcer was critical to their operations, allowing troopers to patrol more remote areas and support other agencies in the area.
|
MSTR | Hot Stocks08:03 EST MicroStrategy appoints Carla Fitzgerald as new Chief Marketing Officer - MicroStrategy announced the appointment of Carla Fitzgerald as the company's new Chief Marketing Officer CMO . A B2B and tech industry veteran with experience spanning three decades, Carla brings a wealth of expertise in go-to-market strategy, revenue growth, and thought-leader positioning to her role at MicroStrategy. Before joining MicroStrategy, Carla served as the CMO of BigBear.ai, a provider of AI-powered decision intelligence solutions for global supply chain and logistics, cybersecurity, and autonomous systems. Her career in technology marketing also includes leadership roles as CMO for Spireon and Smith Micro Software. Her appointment as the new CMO comes at a pivotal time for the company with its recent launch of MicroStrategy AI, the industry's first enterprise-grade, AI-powered business intelligence platform that helps organizations rapidly deploy generative AI applications using trusted data.
|
ASND | Hot Stocks08:03 EST Ascendis Pharma resubmits NDA for TransCon PTH to U.S. FDA - Ascendis Pharma A/S announced that it has resubmitted its New Drug Application for TransCon PTH for the treatment of adults with hypoparathyroidism to the U.S. Food & Drug Administration. The resubmission follows the Type A meeting held with the FDA in late August. "Ascendis Pharma remains committed to providing a treatment option that addresses the underlying disease pathophysiology for patients living with hypoparathyroidism," said Jan Mikkelsen, President and Chief Executive Officer at Ascendis Pharma. "With results from two randomized, double-blind, placebo-controlled clinical trials of TransCon PTH and no new safety concerns identified in follow-up reaching up to four years, we believe TransCon PTH is well-positioned to meet the needs of the hypoparathyroidism community. As no concerns were expressed by the FDA about the clinical data submitted as part of our original NDA, we look forward to working with the agency during its review of our updated manufacturing control strategy for TransCon PTH in the United States."
|
BAESY | Hot Stocks08:03 EST BAE Systems receives order from Royal Australian Navy's Hunter class frigates - BAE Systems has received a contract to deliver multiple shipsets of the Mk 45 Medium Caliber Gun and automated Ammunition Handling System for the Royal Australian Navy's new Hunter class frigates. The Mk 45 gun system will equip the Royal Australian Navy with a common, adaptable gun system that can easily integrate advanced munitions to provide the firepower required to meet the Hunter class deterrence mission. BAE Systems has received a contract to deliver multiple shipsets of the Mk 45 Medium Caliber Gun and automated Ammunition Handling System for the Royal Australian Navy's new Hunter class frigates. Work on the contract will begin in 2023 and finish in 2036. Engineering work will be completed in Minneapolis, Minnesota and production will occur in Louisville, Kentucky.
|
HRT | Hot Stocks08:02 EST HireRight announces Stephen Spears as chief revenue officer - HireRight announced that Stephen Spears has taken over the role of chief revenue officer, or CRO, at HireRight with immediate effect. His appointment follows the retirement of Steve Girdler, the company's previous CRO, who will be staying on with the company in an advisory capacity until early 2024. Reporting to HireRight president and CEO, Guy Abramo, Spears will lead HireRight's go-to-market and customer service organization, with a focus on leading the company's long-term competitive strategy and initiatives to drive growth and support customer retention. In addition to these responsibilities, he will also lead the company's Environmental, Social, and Governance, or ESG, program. Stephen has more than 20 years of extensive go-to-market and leadership experience, including overseeing the strategy, performance, and alignment of revenue operations across multiple organizations at scale. He also managed initiatives to support customers and partners.
|
HBM | Hot Stocks07:59 EST Hudbay Minerals announces redemption of remaining Copper Mountain bonds - Hudbay Minerals announced that its wholly owned subsidiary, Copper Mountain Mining ULC has exercised the redemption option on its senior secured 8% notes. Copper Mountain will redeem the remaining $54.7 million principal amount outstanding of Copper Mountain Bonds on or about November 30, 2023 at a call price equal to 104% of the principal amount being redeemed, plus accrued and unpaid interest to the date of redemption, as prescribed by the bond terms governing the Copper Mountain Bonds. The Copper Mountain Bonds would otherwise mature on April 9, 2026. Hudbay intends to utilize its senior secured revolving credit facility to fund the redemption of the Copper Mountain Bonds. Doing so will further enhance Hudbay's financial flexibility by improving the company's ability to deleverage and repay debt sooner than the 2026 maturity date of the Copper Mountain Bonds.
|
STCGF | Hot Stocks07:48 EST Stack Capital announces normal course issuer bid - Stack Capital Group announced that the Toronto Stock Exchange has accepted a notice filed by Stack Capital of its intention to make a normal course issuer bidwith respect to its outstanding common shares. Stack Capital management believes its share price is undervalued compared to its recently announced Book Value per Share of $11.30. The notice provides that Stack Capital may, during the 12-month period commencing November 17, 2023, and ending no later than November 16, 2024, purchase through the facilities of the TSX and/or alternative Canadian Trading Systems up to 449,000 common shares in total, being 5.0% of the issued and outstanding common shares as of November 7, 2023. The price which Stack Capital will pay for any common shares will be the market price at the time of acquisition. During the period of this NCIB, Stack Capital may make purchases under the NCIB by means of open market transactions. The actual number of common shares which may be purchased pursuant to the NCIB and the timing of any such purchases will be determined by senior management of Stack Capital. The average daily trading volume from May 1, 2023 to October 31, 2023 was of 4,050 common shares. Daily purchases under the NCIB will be generally limited to 1,012 common shares, other than block purchases. All shares purchased by Stack Capital under the NCIB will be cancelled. As of November 7, 2023, there were 8,982,345 common shares of Stack Capital outstanding, and the public float was 8,142,888 common shares. Stack Capital may purchase its common shares, from time to time, if it believes that the market price of its common shares is attractive and that the purchase would be an appropriate use of corporate funds and in the best interests of Stack Capital. In connection with the NCIB, Stack Capital has entered into an automatic share purchase plan with a designated broker to facilitate the purchase of common shares under the NCIB, including at times when Stack Capital would ordinarily not be permitted to purchase its common shares due to regulatory restrictions or self-imposed blackout periods. During restricted or blackout periods, purchases under the ASPP will be determined by the designated broker in its sole discretion based on the purchasing parameters set by Stack Capital in accordance with the rules of the TSX, applicable securities laws and the terms of the ASPP. Outside of the restricted and blackout periods, the timing and amount of purchases under the NCIB will be determined by senior management of Stack Capital. The ASPP has been pre-cleared by the TSX and will become effective on November 17, 2023, concurrently with the commencement of the NCIB. All purchases made under the ASPP will be included in computing the number of common shares purchased under the NCIB. Pursuant to a previous notice of intention to conduct a NCIB, under which Stack Capital sought and received approval from the TSX to purchase up to 461,500 common shares for the period of November 17, 2022 to November 16, 2023, Stack Capital purchased 252,600 common shares through the facilities of the TSX and alternative Canadian Trading Systems for cancellation as of November 7, 2023 at a weighted average price of $6.17 per share. Stack Capital's previous NCIB expires on November 16, 2023.
|
CDRO | Hot Stocks07:46 EST Codere Online sees 2023 net gaming revenue EUR 155M - EUR 165M - Oscar Iglesias, CFO of Codere Online, stated, "Our third quarter results have shown that the combination of a strong brand, high-quality customer acquisitions and an attractive product offering has allowed us to deliver not only strong top line growth but also a significant improvement in profitability, with our first quarter of breakeven Adjusted EBITDA less than two years following our U.S. listing. Based on these strong results and recent trading activity, we now expect to generate between EUR 155-165 million of net gaming revenue and negative EUR 10-18 million in Adjusted EBITDA in 2023, and reaffirm that we expect to generate positive Adjusted EBITDA and cash flow for the full year in 2024."
|
BNXAF | Hot Stocks07:44 EST Banxa Holdings says audit moving to final review stage - Banxa Holdings announces an update on the audit from the Company's audit firm, PKF Antares. PKF has notified Banxa that the audit is moving to the final review stage with Senior Partners of the firm. PKF has provided a revised timeline to complete this final review process and it is anticipated to be completed by December 3, 2023. This revised timeline is tentative due to PKF having challenged Banxa's revenue recognition policy as it relates to revenue recognized on an agency basis. Banxa is fully committed to ensuring all its accounting policies are sound and as such has engaged an independent third party to review its revenue recognition policy which has caused the additional delay in closing this year's audit. Banxa is in the process of compiling supporting documentation to defend its agency revenue recognition policy. Banxa's agency revenue recognition policy has been in place for the past four years. The outcome of Banxa's agency revenue recognition policy review does not have an impact on the financial statements beyond 'revenue' and 'cost of sale'. Gross profit and net income will remain unchanged, regardless. Banxa and PKF are diligently working to finalize the audit as soon as November 30, 2023. This is still well within the deadline provided by the British Columbia Securities Commission of December 29, 2023. Banxa will continue to update the market on a bi-weekly frequency on the audit's progress.
|
ARWYF | Hot Stocks07:41 EST ARway.ai announces four new SaaS subscription deals - ARway.ai announced four new developer SaaS subscription deals starting at $249/month. A wave of new demand for ARway is coming in from around the globe with various use-cases leveraging its groundbreaking augmented reality technology.
|
CMND | Hot Stocks07:39 EST Clearmind Medicine announces results of shareholders meeting - Clearmind Medicine announced that all of the matters put forward before shareholders for consideration and approval at its meeting held on November 14, 2023, as set out in the Company's Management Information Circular dated October 9, 2023, were approved by the requisite majority of votes cast at the Meeting, including a resolution fixing the board of directors at four members, the election of directors of the Company for the ensuing year, a resolution to establish and approve an omnibus equity incentive plan and a resolution approving the directors to effect a consolidation of the common shares in the capital of the Company on the basis of fifty pre-Consolidation Shares for one post-Consolidation Share, or such other lesser consolidation ratio as determined by the Company's board of directors at its sole discretion, in one or more tranches during the twelve months immediately following the Meeting.
|
DPMLF | Hot Stocks07:39 EST Dundee Precious Metals announces results from Coka Rakita prospect - Dundee Precious Metals reported new assay results from its ongoing infill drilling program at the Coka Rakita prospect in eastern Serbia, which continued to confirm the continuity of the mineralization and locally extended the footprint of the deposit to the west and south-west. Additionally, the Company provided an update on its scout drilling program on the oka Rakita licence, highlighting additional potential for manto-like copper-gold skarn mineralization at the Frasen, Dumitru Potok and Rakita North targets. "We are excited to announce these exceptional results from our ongoing drilling program at the high-quality oka Rakita prospect in Serbia, including the best intercept to date with 73 metres at 43 grams per tonne gold and 0.12% copper," said David Rae, President and Chief Executive Officer of Dundee Precious Metals.
|
BWMN | Hot Stocks07:38 EST Bowman Consulting Group acquires High Mesa in 'immediately accretive' deal - Bowman Consulting Group announced the acquisition of High Mesa Consulting Group or High Mesa, a multi-disciplinary consulting firm headquartered in Albuquerque, New Mexico. Founded in 1977, High Mesa provides land and UAV or drone based surveying, mapping, and geospatial services; sub-surface utility infrastructure engineering, inspection, and mapping; civil engineering; and planning services throughout New Mexico, Eastern Arizona, and Southwestern Colorado. High Mesa is Bowman's tenth acquisition in 2023. "High Mesa is a great addition to Bowman and immediately expands our reach into growing markets we do not currently serve," said Gary Bowman, chairman and CEO of Bowman...Financed with a combination of cash, seller notes and equity, the acquisition falls within previously discussed target multiple and operating metric ranges, and is expected to be immediately accretive. The Company anticipates the acquisition will initially operate at an annualized net service billing run rate of approximately $4M. More detailed information on M&A activities, pipeline and guidance updates are provided in connection with scheduled quarterly and annual communications.
|
FEMY PMCB | Hot Stocks07:37 EST Femasys announces upfront investment of $6.85M by PharmaCyte - Femasys (FEMY) announced a strategic upfront investment of $6.85 million by public biotech company, PharmaCyte Biotech (PMCB) and other healthcare investors. "We are thrilled to announce this strategic investment, which coupled with other recent financing activities, will allow Femasys to commercialize our infertility-related products, FemaSeed and FemVue. This financing will enable us to implement a targeted commercial team to increase our revenue potential, while delivering on our mission to bring safe, accessible, and novel options to women," said Kathy Lee-Sepsick, founder, president and chief executive officer of Femasys. "In addition, this financing supports Femasys' continued progress of our FemBloc pivotal clinical trial as we advance this important non-surgical solution for permanent birth control." The strategic investment in Femasys is in the form of $6.85 million aggregate principal amount of a senior unsecured convertible note which matures November 2025 and is convertible at $1.18. Under the terms of the investment, the investors were also issued two series of warrants: warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.18 per share expiring one year from issuance and warrants to purchase approximately 5.8 million shares of common stock at an exercise price of $1.475 per share expiring five years from issuance. If exercised for cash, these warrants could result in proceeds of up to an additional $15.4 million.
|
SGII | Hot Stocks07:37 EST American Battery Materials issues clarification on reverse stock split - American Battery Materials issued a clarification of the status of the Company's 1-for-300 reverse stock split. As announced yesterday by FINRA on its Daily List, FINRA completed its review and the reverse stock split was to become effective on the OTC Marketplace at 8:00 AM Eastern time on November 15, 2023. The Company was subsequently informed by FINRA that the Company's transfer agent, Equiniti, failed to confirm with DTC that it was engaged to serve as the exchange agent to process the reverse stock split. As such, the reverse stock split has been rescinded pending resolution of the engagement of Equiniti. The Company is in contact with Equiniti, DTC, and FINRA to resolve all issues with Equiniti. The Company expects to have the reverse stock split go forward as soon as possible.
|
CGTX | Hot Stocks07:36 EST Cognition Therapeutics presents preclinical data on sigma-2 modulators - Cognition Therapeutics is presenting in vivo preclinical results at the Society for Neuroscience's annual meeting illuminating the role of sigma-2 receptor modulators, including CT1812, in models of Alzheimer's and Parkinson's diseases. The effect of two chemically distinct -2 receptor modulators in a mouse model of Alzheimer's disease on gene and protein expression are presented. Data shed light on the molecular mechanisms and build upon previous studies in this same mouse model where Cognition's lead candidate, CT1812 was previously shown to decrease binding of Abeta oligomers to neuronal synapses and ameliorate cognitive deficits. Mary Hamby, Ph.D., Cognition's VP of research, explained, "These findings help to broaden our understanding of the role of the -2 receptor in central nervous system diseases, and support continued discovery and development of candidates that modulate this therapeutic target for Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease."
|
AIM | Hot Stocks07:33 EST AIM ImmunoTech expects cash to fund operations through key milestones - As of September 30, 2023, AIM reported cash, cash equivalents and marketable investments of $22.4 million. Based on management's current expectation, the Company's cash runway is expected to fund operations through multiple key milestones.
|
ICCM | Hot Stocks07:32 EST IceCure Medical asks fro review from FDA for the De Novo Classification Request - IceCure Medical announced it has filed a request for supervisory review under 21 CFR 10.75 with the FDA regarding the agency's denial of the Company's De Novo Classification Request for treating patients with early-stage, low risk breast cancer. IceCure filed the De Novo request with the FDA in October 2022 based on interim data from its ICE3 breast cancer study for the Breakthrough Indication of early-stage low-risk breast cancer patients. The interim ICE3 results, which estimate a five-year 95.7% recurrence free rate, and 100% doctor and patient satisfaction with cosmetic results, were submitted in the De Novo request in an effort to make the breakthrough minimally-invasive cryoablation procedure available to women in the U.S. sooner. On September 20, 2023, IceCure announced that the FDA denied its De Novo request. The ICE3 study is expected to be completed in the Q1 of 2024 following the last patient's five-year follow-up exam. Furthermore, the FDA's decision regarding the De Novo Classification request for breast cancer has no effect on ProSense's FDA cleared authorization for other indications in the U.S., and patients continue to have access to and benefit from ProSense for those indications. Outside of the U.S., ProSense is approved for early-stage breast cancer in numerous countries, including in the European Union, Brazil, and China.
|
SXTP | Hot Stocks07:31 EST 60 Degrees Pharmaceuticals announces Type C Meeting with FDA for tafenoquine - 60 Degrees Pharmaceuticals announced that the U.S. Food and Drug Administration has granted a Type C meeting with the Company to consult on the path forward in developing the tafenoquine regimen of ARAKODA for a potential indication in treating hospitalized babesiosis patients. The meeting will take place on January 15, 2024. Tafenoquine is approved for malaria prophylaxis in the United States under the product name ARAKODA. The safety of the approved regimen of tafenoquine for malaria prophylaxis has been assessed in five separate randomized, double-blind, active comparator, or placebo-controlled trials for durations of up to six months. Tafenoquine has not been proven to be effective for treatment or prevention of babesiosis and is not approved by the FDA for such an indication. The efficacy and safety of 8-aminoquinolines, a class of drugs that includes tafenoquine and primaquine, for prevention and treatment of malaria is well established. The appearance of several case studies of tafenoquine use for babesiosis in the literature suggests that the drug is being used for this purpose in practice of medicine. The Company is planning an adequate and well controlled clinical study to evaluate this use systematically.
|
IDR | Hot Stocks07:26 EST Idaho Strategic announces results of 2023 trenching program at Lemhi Pass - Idaho Strategic Resources announces results of its 2023 trenching program at Lemhi Pass. A total of 1,070 linear feet was divided to construct eight trenches over three prospects. The three historical prospects known as In-Trust, Sparky, and Independence mark the first prospects out of IDR's expansive land position to be tested in the district. IDR maintains approximately 11,425 acres of unpatented claims and state lease land at Lemhi Pass. Two of the three In-Trust trenches encountered strong REE mineralization associated with faults. The 13 samples in the table below assay up to 3.28% total rare earths and average 1.5% TREE. Of note, are very strong enrichments of neodymium, praseodymium, samarium, and dysprosium. These elements are used in the manufacture of rare earth permanent magnets and are among the most valued of all the rare earth elements. In the listed assays, the distribution of rare earth elements is 58% Nd, 8% Pr, 8% Sm, and 2% Dy. Incredibly, these four components combined account for up to 76% of the total rare earth element percentage. At Sparky, four samples collected from material during trenching returned the highest published total rare earth elements assay in the Lemhi Pass district to date. These samples, although not in place, are considered representative of the mineralization source below. The trenching was unable to uncover structural features as the site had been historically excavated and reclaimed and the bedrock proved deeper than the excavator limits. The mineralized rock samples from Sparky show yellow-brown to red-brown frothy, boxwork textured rock, flooded with golden brown jasperoidal material. Similar to the results from the In-Trust trenches, the samples from the trench at the Sparky prospect show very strong enrichments of neodymium, praseodymium, samarium and dysprosium,
|
BG | Hot Stocks07:26 EST Bunge and Musim Mas Group announce a collaboration - Bunge and Musim Mas Group announced a collaboration to promote the use of sustainable practices among smallholder farmers in Sambas, West Kalimantan, Indonesia. The collaboration, co-funded by Bunge and Musim Mas through 2025, aims to train more than 1,000 independent smallholders in sustainable production of palm oil. The partnership aligns with the Agriculture Sector Roadmap to 1.5 degrees convened by the Tropical Forest Alliance, designed to halt commodity-linked deforestation in line with the 1.5 degrees pathway while enhancing the livelihoods of smallholder farmers and supporting the sector's transformation toward forest-positive land-use management.
|
ARAAF | Hot Stocks07:24 EST Aclara Resources announces R&D tax rebate from Government of Chile - Aclara Resources announced that REE UNO SpA, its wholly owned subsidiary that holds 100% stake in the Penco Module has received a tax rebate of approximately $2.1 million from the Corporacion de Fomento de la Produccion for Research and Development expenses related to the installation and operations of the Pilot Plant. CORFO, which is the Chilean government institution in charge of promoting the production of goods and services and economic regional growth, has validated the pilot plant R&D expenses and determined this project to be key to the future production of the rare earths necessary for the manufacturing of permanent magnets used in wind turbines, electric vehicles, and other technologies vital to the energy transition.
|
TRU | Hot Stocks07:23 EST TransUnion to shift additional roles to GCCs, eliminate positions to cut costs - TransUnion announced the next step in its ongoing, multi-year transformation effort to optimize its operating model and advance its market-leading technology. The Company will transition additional roles to its successful Global Capability Centers to improve productivity, reduce costs and fund growth. TransUnion will also leverage Neustar's cloud-native technology to create its next-generation integrated data management, identity resolution, analytics and delivery platform. The Company believes these actions will reduce costs, accelerate innovation and increase organic growth. The Company expects to deliver $120 to $140 million of annualized operating expense savings and a $70 to $80 million capital expenditure reduction in 2026 relative to 2023 levels. Approximately half of the operating expense savings, which exclude depreciation and amortization, are expected to be realized in 2024. This initiative encompasses two components: Optimize Operating Model: TransUnion established its award-winning GCC network in 2018 to centralize, standardize and automate work in locations with deep talent pools. Since then, the network has grown to more than 4,000 employees, or about one-third of TransUnion's employee base, in India, South Africa and Costa Rica, supporting a wide range of functions. The Company plans to transition additional roles to the GCC locations over the course of the next two years, driving material cost savings and productivity benefits. In addition, the Company plans to eliminate roles in the near-term to further reduce operating expenses. Expand Technology Capabilities: TransUnion expects to successfully complete its cloud migration, called Project Rise, by the end of 2024 as planned. This initiative migrates the majority of TransUnion's technology applications to a new software foundation within leading public clouds. TransUnion intends to further leverage Neustar's state-of-the-art technology to streamline its product delivery platforms, achieve material savings and increase innovation velocity. This new, integrated product platform, branded OneTru, will provide customers with seamless access to TransUnion's broad portfolio of data, solutions and capabilities for more rapid product development and commercialization. To capture the benefits, TransUnion expects to incur approximately $355 to $375 million of one-time pre-tax expenses, with the majority incurred by the end of 2024. Employee separation and facility exit costs are expected to make up approximately $155 million of the total. The remaining expense includes approximately $65 million already planned and communicated to complete Project Rise plus approximately $145 million to implement OneTru and optimize the operating model. Capital expenditures are expected to increase to 9 percent of revenue in 2024 and return to 8 percent in 2025. In 2026 and going forward, the Company expects capital expenditures to be 6 percent of revenue. Altogether, the program is expected to impact approximately 10 percent of the Company's current workforce through relocation to the GCC locations and position eliminations. TransUnion expects to make these investments while continuing to prioritize debt prepayment with a targeted net leverage ratio of 3.0x.
|
VSEC | Hot Stocks07:22 EST VSE Corp. affirms FY23 revenue growth outlook at 29% - In its Investor Day presentation yesterday, VSE Corp. announced it is on track to grow revenue 29% vs. 2022 at about $860M at the midpoint vs. consensus $884.5M and adjusted EBITDA of $100M-$119M, while "delivering strong profitability after recent significant investments". The company also sees Q4 free cash flow of $15M-$20M. Reference Link
|
MURA | Hot Stocks07:19 EST Mural Oncology launches to advance cytokine immunotherapies - Mural Oncology launched as an independent, publicly traded, clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Mural's ordinary shares will begin trading on the Nasdaq Global Market tomorrow, November 16th, under the ticker symbol "MURA". Mural Oncology's pipeline is built to address difficult-to-treat tumor types where checkpoint inhibitors are not effective. The Company's lead product candidate, nemvaleukin alfa, is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2, while mitigating the hallmark toxicities of native IL-2 in difficult-to-treat cancers with high unmet need. Nemvaleukin is currently in two potentially registrational studies: one for the treatment of mucosal melanoma as a monotherapy and one for the treatment of platinum-resistant ovarian cancer in combination with pembrolizumab. In addition to nemvaleukin, Mural Oncology has discovery-stage programs in IL-18 and IL-12, focused on proinflammatory cytokines that leverage the Company's immune cell modulation expertise and protein engineering capabilities. This multi-faceted approach to cytokine engineering is aimed at maximizing the utility of identified cytokines and includes binding selectivity, tumor-targeting, half-life modification, and stable fusion proteins. Mural Oncology's executive officers: Caroline Loew, Ph.D., chief executive officer, was previously president and chief executive officer of Glympse Bio. Adam Cutler, chief financial officer, was previously chief financial officer of both Q32 Bio and Molecular Templates. Vicki Goodman, M.D., chief medical officer, was previously executive vice president, product development & medical affairs, and chief medical officer of Exelixis. Maiken Keson-Brookes, chief legal officer, previously served as chief legal officer and corporate secretary of Rubius Therapeutics. Mural Oncology's board of directors: Scott Jackson, MBA, chairman of the board, previously served as chief executive officer and as a member of the board of directors of Celator Pharmaceuticals. Susan Altschuller, Ph.D., MBA, currently serves as chief financial officer for Cerevel Therapeutics. Francis Cuss, M.B., B.Chir., FRCP, is the retired executive vice president, chief scientific officer, and head of research and development of BMS. Benjamin Hickey, MBA, currently serves as the executive vice president, chief commercial officer of Mirati Therapeutics.
|
CNC | Hot Stocks07:16 EST Centene appoints Susan Smith as COO - Centene announced the appointment of Susan Smith as its COO, effective January 1, 2024. As COO, Smith will report to Centene President Ken Fasola and will be responsible for core business operations, population health, the enterprise transformation office, provider experience and quality. She has worked at Centene since June 2023. Smith brings nearly two decades of expertise in the payer space, having spent 19 years at Humana. She most recently served as SVP of Clinical, Quality and Enterprise Solutions President, where she had oversight of quality; clinical strategy, analytics and product development; clinical operations; risk adjustment; and experience transformation. Prior to this role, Smith served as SVP of Clinical Solutions and SVP of Medicare. Among numerous accomplishments during her tenure, she is credited for her work in leading Humana's efforts to improve its Star ratings and member quality; in playing a central role in the design and development of Medicaid operations for Humana; and for her experienced leadership creating sustainable organizations and processes during transformative times. She held other leadership roles, including SVP of Healthcare Quality Reporting and Improvement, and Vice President of Risk Adjustment, among others. Ms. Smith started her career at Colgate-Palmolive.
|
LCUT | Hot Stocks07:15 EST Lifetime Brands completes Term Loan B amendment, extension - Lifetime Brands announced the completion of the Term Loan B Amendment and Extension. On November 14, 2023, the Company's Term Loan B in the principal amount of $198.7 million due February 2025 has been amended and extended. The Term Loan, as amended and extended, will have a principal amount of $150.0 million and mature in August 2027. In connection with the amendment and extension, the Company borrowed on its asset-based loan facility to pay down $48.7 million of principal amount of the Term Loan B plus approximately $9 million to pay the original issue discount and related fees and expenses.
|
HLGN | Hot Stocks07:15 EST OTC Markets Group welcomes Heliogen to OTCQX - OTC Markets Group announced Heliogen, a concentrated solar energy company, has qualified to trade on the OTCQX Best Market. Heliogen, Inc. previously traded on the New York Stock Exchange. Heliogen, Inc. begins trading on OTCQX under the symbol "HLGN."
|
VRSK | Hot Stocks07:13 EST Verisk Analytics announces launch of FairCheck - Verisk announced the launch of FairCheck, a solution designed to help insurers test their personal lines models and variables to respond to regulatory changes. FairCheck comprises a customizable, scalable methodology and consultative service to help evaluate and mitigate the potential for unfairly discriminatory outcomes, including in advance of regulatory filings. "We took a proactive approach in assessing our own personal auto rating model to determine whether there were unfair pricing differentials regarding race," said Adrian Cuc, senior vice president of analytics at Verisk. "We discovered that race was not a contributing factor in our model. The analysis serves as a foundation for our FairCheck solution that is customizable to assess individual insurer models, different variables within their models and various geographical regions for potential unintended bias. It is a meaningful step in measuring and understanding what impact, if any, race may play in insurer pricing models. By understanding its potential impact, an insurer can determine whether they need to begin to evaluate and mitigate the potential for unfairly discriminatory outcomes."
|
TORXF | Hot Stocks07:13 EST Torex Gold Resources receives approval for in-pit tailings deposition - Torex Gold Resources announces the Company has received approval from Mexico's Secretariat of Environment and Natural Resources regarding an amendment to the key environmental permit for the Media Luna Project, which will allow for the deposition of tailings into the mined-out Guajes open pit. Jody Kuzenko, President & CEO of Torex, stated: "The amendment to the MIA is the last environmental approval required for the operational phase of the Media Luna Project and allows us to move forward with the deposition of tailings into the mined-out Guajes open pit. The switch to in-pit tailings deposition from filtered and dry-stacked tailings will coincide with the planned commissioning of the copper and iron sulphide flotation circuits as well as concentrate filtering and handling facilities. As outlined in the March 2022 Technical Report, approximately half of the tailings produced over the life of the Morelos Complex are expected to be deposited within the Guajes open pit, with the remainder deposited underground as cemented paste backfill. Work to prepare the Guajes pit for future tailings deposition will commence shortly in preparation for our plans to start depositing tailings in late 2024. Receipt of the MIA amendment marks another significant project de-risking milestone and further demonstrates the ongoing support of local communities and the endorsement of State and Federal Governments of both the social and environmental facets of the Morelos Complex."
|
LIND DIS | Hot Stocks07:13 EST Lindblad Expeditions extends and expands relationship with National Geographic - Lindblad Expeditions Holdings (LIND) announced the long-term extension and expansion of the Lindblad Expeditions brand's strategic relationship with renowned exploration and scientific discovery brand National Geographic. Under the new agreement, the two companies have extended their industry-defining 20-year relationship for 17 additional years, with a commitment through 2040 that will allow the brand to reach new worldwide audiences through three compelling new market opportunities including: global rights to the National Geographic brand for expedition cruises, which will enable Lindblad Expeditions to increase its fleet capacity of 17 intimately scaled exploration ships and expand into additional market segments; leverage of The Walt Disney (DIS) as an affiliate of National Geographic Partners to distribute product through Disney's powerful sales channels and support robust joint marketing campaigns; and enhancements to the onboard guest experience with more immersive storytelling and experiences connected to the National Geographic brand. One of the most impactful elements of this new agreement is the distribution of the company's products through The Walt Disney Company's powerful sales channels. This distribution will be instrumental in reaching key new-to-expedition and new-to-brand travelers around the world, thereby growing the company's consumer base to drive additional capacity and earnings growth in the years ahead.
|
LTHCF | Hot Stocks07:12 EST Lithium Ionic reports additional results from program at Bandeira Project - Lithium Ionic reports additional results from the ongoing drilling program at the Bandeira Project, located in northern Minas Gerais State, Brazil. The Company is rapidly advancing Bandeira, situated within the emerging "Lithium Valley", where two lithium producers currently operate. Blake Hylands, P.Geo., Chief Executive Officer of Lithium Ionic, commented, "These latest drill results continue to bolster our efforts to expand and enhance the Bandeira project for our upcoming Feasibility Study. The growth trajectory of this deposit since we began drilling it in April 2022 is a testament to its significance within our large portfolio of properties in this belt and will continue to be a key driver of our success. Bandeira represents just a fraction of our land holdings, and our team strongly believes that our success at this property could be replicated at our other properties in the region with the same effort."
|
AMLI | Hot Stocks07:12 EST American Lithium announces Peruvian Superior Court ruled in favor of subsidiary - American Lithium announces that a three judge tribunal of Peru's Superior Court SALA 4 specialized in administration disputes has unanimously upheld the ruling of the lower court judge from Court SALA 6 announced on November 2, 2021 in favour of the Company's subsidiary, Macusani Yellowcake in relation to title over 32 disputed concessions out of 172 owned by Macusani. The Court ruling, consistent with prior legal proceedings, clearly establishes that Macusani is the rightful owner of these concessions. Furthermore, it highlights that the action launched by INGEMMET and MINEM in October 2018 was baseless and unsubstantiated. Simon Clarke, CEO of American Lithium states, "We are extremely pleased with this ruling as it validates the Company's contention that the actions of INGEMMET and MINEM were inappropriate from the start of this process. It is very encouraging to see that the Peruvian Judicial System continues to support the facts of this case and has found against INGEMMET and MINEM for the actions they have taken. The Company has never lost title over the disputed concessions, which only represent a small fraction of our leases. For this reason, we have continued to advance the Falchani project and look forward to the announcement of additional progress shortly."
|
BITF | Hot Stocks07:10 EST Bitfarms locks in power cost at 2.1 cents per kWh fixed rate at Rio Cuarto - Bitfarms has entered into a prepaid contract with its Argentinian private power producer to receive power at Rio Cuarto at the rate of 2.1 cents per kWh plus VAT for the months November 2023 through April 2024, which benefits from seasonally lower natural gas prices in Argentina. "With Argentina currently contributing 23% of our global hashrate, this 6-month fixed price agreement will significantly lower our blended cost of power," said Geoff Morphy, President and CEO of Bitfarms. "By comparison, in Q3 2023 our all-in cost of power at Rio Cuarto was slightly over 3.2 cents per kWh, and in October 2023, which was our first month operating that facility at full capacity, our all-in cost was 2.2 cents per kWh. Accordingly, with lower power costs at Rio Cuarto over the next 6 months, we expect the average cost of power at our Argentine operations in its first year to be around 2.5 cents per kWh plus taxes, driving down our corporate average cost of power for the full year."
|
CMMB | Hot Stocks07:10 EST Chemomab Therapeutics receives FDA Fast Track Designation for CM-101 - Chemomab Therapeutics announced that the U.S. FDA has granted CM-101 Fast Track designation for the treatment in adult patients of primary sclerosing cholangitis, a fibrotic liver disease that can result in liver transplant, cancer and early death.
|
RPTX | Hot Stocks07:09 EST Repare to advance RP-1664 and RP-3467 into Phase 1 clinical trials in 2024 - Repare Therapeutics disclosed polo-like kinase 4 or PLK4 as the target of its RP-1664 development program and reported comprehensive preclinical data for both RP-1664 and the Company's Pol inhibitor, RP-3467. RP-1664 is a potential first-in-class, selective, oral PLK4 inhibitor that is synthetic lethal with TRIM37 amplification or overexpression in solid tumors. Tumors rely on PLK4 for survival in the presence of high levels of TRIM37. Preclinical studies demonstrate RP-1664 drives potent synthetic lethality in TRIM37-high tumor models, both in vitro and in vivo. Elevated TRIM37 is a feature found across a range of solid tumors and in nearly all high-grade neuroblastomas. RP-3467 is a potential best-in-class inhibitor of DNA polymerase theta, or Pol. Pol is a synthetic lethal target associated with homologous recombination deficiency tumors, including those with BRCA1/2 mutations or other genomic alterations. Data suggest that RP-3467 works synergistically with therapies that result in double stranded DNA breaks, such as PARP inhibition, radioligand therapy and multiple chemotherapies and antibody-drug conjugates . Additionally, initial data suggest that Pol inhibition may interfere with mechanisms central to the development of PARPi resistance....We look forward to advancing both RP-1664 and RP-3467 into Phase 1 clinical trials in 2024."
|
TNXP | Hot Stocks07:09 EST Tonix completes clinical stage of Phase 3 RESILIENT study of TNX-102 SL - Tonix Pharmaceuticals Holding announced the completion of the clinical phase of the Phase 3 registration-quality, double-blind, placebo-controlled RESILIENT1 study of TNX-102 SL2 5.6 mg for the management of fibromyalgia. A total of 457 patients were enrolled in this multi-site study in the U.S. Topline results are expected in late December 2023. If successful, it is expected to be the final, well-controlled efficacy trial required for submission of a New Drug Application for approval by the U.S. Food and Drug Administration. "There are an estimated 6-12 million individuals in the U.S. suffering from this debilitating condition, most of whom are women," said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. "TNX-102 SL is a centrally-acting, non-opioid analgesic bedtime medication designed to be used on a chronic basis for the management of fibromyalgia. We believe TNX-102 SL works by improving sleep quality, which leads to improvement of other symptoms. In previous studies, TNX-102 SL showed broad coverage across the symptoms of fibromyalgia, including chronic widespread pain, fatigue and sleep disturbance."
|
TLRY | Hot Stocks07:07 EST Tilray expands cannabis beverage portfolio with new THC, CBG, CBD, innovations - Tilray Brands announced a bold new range of cannabis-infused beverages from its renowned brands XMG and Mollo. Recognized for their diverse flavours and innovative cannabinoid profiles, including THC, CBG, and CBD, these brands are reshaping the cannabis beverage market with unparalleled variety and quality. Blair MacNeil, President, Tilray Canada, said, "Tilray's commitment to innovation and consumer satisfaction is exemplified by our expansive beverage offerings from XMG and Mollo. With the success of recent introductions from other Tilray brands such as Solei and RIFF, we have firmly positioned ourselves as leaders in the cannabis beverage market. Both XMG and Mollo have consistently been top choices for Canadian consumers, and these new releases, highlighting unique cannabinoid combinations and premium formulations, underscore our dedication to providing diverse and quality brand experiences."
|
ALKS | Hot Stocks07:07 EST Alkermes completes separation of oncology business - Alkermes announced that it has completed the separation of its oncology business into Mural Oncology, a new, independent, publicly traded company. Alkermes is now a pure-play, profitable neuroscience company that will continue its work to develop innovative medicines for people living with difficult-to-treat psychiatric and neurological disorders. Mural Oncology will begin "regular way" trading on the Nasdaq Global Market under the stock ticker symbol "MURA" on Nov. 16, 2023. Alkermes will continue to trade under the Nasdaq ticker symbol "ALKS."
|
MANU | Hot Stocks07:06 EST Manchester United's CEO Richard Arnold to step down, Stewart named interim - Manchester United announces that Richard Arnold has decided to step down as Chief Executive Officer of Manchester United after 16 years with the club. Patrick Stewart will take over as interim CEO, in addition to his existing role as General Counsel, with Richard continuing to provide transitional support until the end of December. A search process will be carried out for a new permanent CEO. Joel Glazer, Executive Co-Chairman, said: "I would like to thank Richard for his outstanding service to Manchester United over the past 16 years, and wish him all the best for his future endeavours. We are fortunate to be able to call on the deep knowledge and experience of Patrick Stewart to provide interim stability and continuity as we embark on a search for a new permanent CEO." Patrick Stewart said: "Together with my leadership team colleagues, my job will be to ensure that the club's foundations remain stable while we embrace changes that can make us stronger over the long term, both on and off the pitch, and to support the search for a new permanent CEO."
|
GRPH | Hot Stocks07:04 EST Graphite Bio, Lenz Therapeutics to combine in all stock transaction - Lenz Therapeutics and Graphite Bio announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The lead programs of the combined company will address presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over the age of 45. The combined company is expected to trade on Nasdaq under the ticker symbol (LENZ). In connection with the merger, Graphite Bio has entered into a subscription agreement for a PIPE financing that is expected to close concurrently with the completion of the merger of $53.5M, with a syndicate of healthcare investors led by Lenz's existing investors and including participation from new investors. The merger is subject to stockholder approval of both companies, the effectiveness of a registration statement to be filed with the U.S. Securities and Exchange Commission to register the securities to be issued in connection with the merger, and the satisfaction of customary closing conditions. With the cash expected from both companies at closing and the proceeds of the concurrent PIPE financing, the combined company is expected to have approximately $225M of cash or cash equivalents. Graphite Bio is expected to contribute $115M to the combined entity and expects to pay a dividend to Graphite Bio shareholders of approximately $60M at the close of the transaction. Upon close, key healthcare investors in the combined company will include Versant Ventures, RA Capital Management, Alpha Wave Global, Point72, Samsara BioCapital, Sectoral Asset Management, RTW Investments and others. It is expected that the net proceeds from the merger and concurrent financing will allow the combined company to continue to build infrastructure and successfully commercialize Lenz's lead product candidate, subject to successful completion of the ongoing Phase 3 trials, New Drug Application, or NDA, submission and subsequent FDA approval.
|
GT | Hot Stocks07:03 EST Goodyear Tire announces transformation plan, 'Goodyear Forward' - The Goodyear Tire & Rubber Company announced a transformation plan - "Goodyear Forward" - to optimize its portfolio, deliver significant margin expansion and reduce leverage to drive sustainable and substantial shareholder value creation. This plan follows a comprehensive evaluation by the Strategic and Operational Review Committee of the Board of Directors to evaluate all strategic, operational and financial opportunities to maximize value. "Our transformation plan represents a clear path to create a more profitable and focused Goodyear," said Goodyear Chairman, CEO and President Richard J. Kramer. "The Review Committee explored all value maximizing opportunities and identified specific, detailed initiatives to streamline our portfolio, expand margins and fortify our balance sheet, and do so with expediency. Building on our strengths, this plan will enable Goodyear to enhance and expand our leadership position, deliver profitable growth across markets, create significant value for our shareholders and - ultimately - lay the foundation for success for the next 125 years." "This plan is the result of a comprehensive, bottom-up assessment of Goodyear's business, led by the Review Committee," said Laurette T. Koellner, Independent Lead Director of Goodyear's Board. "The full Board supports this plan and is confident it will deliver substantial and durable value creation for shareholders. We appreciate the constructive input of our shareholders throughout this process." On behalf of Elliott Investment Management, one of Goodyear's largest investors, Senior Portfolio Manager Marc Steinberg and Portfolio Manager Austin Camporin said, "We believe the 'Goodyear Forward' transformation plan represents a significant set of steps toward a stronger and more profitable Goodyear. We thank Rich for his leadership and the Review Committee for its collaborative engagement, and we look forward to continuing our dialogue with the Company as it implements these initiatives and works to deliver the substantial upside value that we see for all Goodyear shareholders." The Review Committee consisted of five directors, including two new independent directors appointed in July 2023. Over the course of 16 weeks, the Review Committee engaged in deep analysis and deliberation with assistance from industry-leading financial advisors and consultants. The review culminated in a detailed and actionable plan to streamline the business, accelerate growth and enhance competitive positioning. The full Board will oversee the execution of the Goodyear Forward plan and remains committed to the ongoing assessment of value-enhancing opportunities. The Company will provide regular updates to shareholders on its progress executing the plan. Goodyear Forward will deliver: Gross proceeds in excess of $2 billion from portfolio optimization. Following a comprehensive assessment of all assets, Goodyear has determined to actively pursue strategic alternatives for its Chemical business, the Dunlop brand and the Off-the-Road equipment tire business. Cost reduction actions driving an annual, run-rate benefit of $1 billion by the end of 2025. The Company has initiated a specific and actionable cost reduction plan encompassing footprint actions and plant optimization; purchasing; SAG; supply chain; and R&D. With many unique workstreams, Goodyear has a clear line-of-sight to 100% of the cost savings. Top line actions driving an annual, run-rate benefit of $300 million by the end of 2025. The Company has identified opportunities in North America to optimize brand and tier positioning, rationalize SKUs, increase customer and channel profitability and enhance coverage in premium product lines. Segment operating income margin doubling to 10% by the end of 2025. With the benefits of cost reduction and top line actions, and net of the impact of expected asset sales and inflation, the Company expects segment operating margin to double from approximately 5% in 2023 to 10% by the fourth quarter of 2025. Net leverage of 2.0x - 2.5x by the end of 2025. Goodyear will strengthen its financial profile through enhanced earnings, cash flow generation and debt reduction, moving the Company closer toward an investment-grade rating. The company expects debt reduction of approximately $1.5 billion, net of approximately $1.1 billion for restructuring.
|
GT | Hot Stocks07:02 EST Goodyear Tire CEO Rich Kramer to retire in 2024 - The Goodyear Tire & Rubber Company announced that Richard Kramer has informed the Board of his plans to retire as Chairman, CEO and President of the company in 2024. In connection with Kramer's planned retirement previously discussed with the Board as part of the company's ongoing and active succession planning process, the Goodyear Board retained a leading executive search firm to execute a search considering both internal and external candidates.
|
ACM | Hot Stocks06:58 EST Aecom appointed to Uisce Eireann's new Capital Works PMO Framework - AECOM announced it has been appointed to Uisce Eireann's new Capital Works PMO Framework and is the only supplier to be appointed to all four lots on the program. In this role, AECOM will support Uisce Eireann, Ireland's public water utility, in its mission to transform the delivery of water services, including providing cleaner, safer drinking water and more effective management of wastewater, and to support social and economic growth. AECOM will provide a range of services including project and program management, design, stakeholder consultation, and site supervision. Projects will include the construction and upgrading of water and wastewater treatment plants, water and sewerage networks, and dams and reservoirs infrastructure. The five-year contract, with the option to extend by a further two years, replaces and combines several previous frameworks under one program.
|
BVH | Hot Stocks06:56 EST Bluegreen Vacations subsidiary acquires Stonewater Cove Resort and Club - Bluegreen Vacations Holding announced that Bluegreen/Big Cedar Vacations a joint venture between the Company and Bass Pro Shops, has acquired the Stonewater Cove Resort and Club, a wilderness retreat located in Stone County, Missouri. Located on 470 acres within the Mark Twain National Forest in the Ozark Mountains, Stonewater Cove is a picturesque destination surrounded by pristine forests, overlooking Table Rock Lake. The resort currently features 38 lakeside cottages, a club house with restaurant, pool and hot tub, boat dock, miniature golf course, ziplines, hiking trails, and other outdoor amenities.
|
AAP | Hot Stocks06:52 EST Advance Auto Parts falls 11% to $51.82 after cutting FY23 EPS guidance
|
PHVS | Hot Stocks06:51 EST Pharvaris names Stefan Abele, Ph.D., as Chief Technical Operations Officer - Pharvaris announced the appointment of Stefan Abele, Ph.D., as Chief Technical Operations Officer. In this role, he will be responsible for all chemistry, manufacturing, and controls activities, supply chain, and program management as Pharvaris progresses into late-stage clinical development. Dr. Abele joins Pharvaris with more than 20 years of experience in process development, end-to-end Active Pharmaceutical Ingredients supply chain, cross-functional CMC activities, GMP manufacturing, global vendor management, and people leadership.
|
PERF | Hot Stocks06:50 EST Perfect announces partnership with Sona Dermatology - Perfect announced a new partnership with the leading dermatology company, Sona Dermatology. Through this partnership, Sona Dermatology will integrate Perfect Corp.'s award-winning AI-powered Skin Diagnostic technology into their patient consultation experience. This technology is poised to enhance Sona Dermatology's online experience by enabling patients to receive instant visualized skin evaluations as well as treatment and product recommendations in seconds. Sona Dermatology provides its patients with the latest innovations in skincare and skin health services. The brand offers clinical and cosmetic dermatology care overseen by Board Certified Dermatologists who utilize the latest techniques and technology to provide services such as Injectables, Laser/Microneedling skincare, Laser Hair Removal, skincare regimens, and more.
|
AAP LOW | Hot Stocks06:49 EST Advance Auto Parts names Ryan Grimsland as CFO - Advance Auto Parts (AAP) announced that it has appointed Ryan Grimsland as executive vice president and CFO, effective November 27. Tony Iskander, who has served as interim CFO since August 2023 will continue in his role as senior vice president, finance and treasurer. Grimsland brings more than 20 years of corporate finance, treasury, financial planning, and retail strategy and transformation experience. Most recently, Grimsland served as senior vice president, strategy and transformation at Lowe's Companies (LOW).
|
CHGG MS | Hot Stocks06:48 EST Chegg announces accelerated share repurchase agreement with Morgan Stanley Bank - Chegg (CHGG) announced that it has entered into an accelerated share repurchase agreement, or ASR, with Morgan Stanley (MS) Bank, National Association, to repurchase $150M of Chegg's common stock. Under the ASR, Chegg will make an initial payment of $150M to Morgan Stanley Bank, National Association, and will receive an initial delivery of approximately 13.5M shares of its common stock by November 15. The final number of shares to be repurchased will be based on the volume-weighted average price of Chegg's common stock during the term of the ASR, less a discount. The final settlement of the ASR is expected to occur by the Q2 of 2024. The ASR transaction will be effectuated pursuant to Chegg's previously announced $2.2B securities repurchase program. As of October 31, 2023, $153.7M remained available for future repurchases under this program and $3.7M will remain available after completion of the ASR. There is no expiration date for the repurchase program, and it will continue until otherwise suspended, terminated or modified at any time for any reason by our board of directors.
|
AAP | Hot Stocks06:47 EST Advance Auto Parts launches $150M cost reduction program
|
AAP | Hot Stocks06:46 EST Advance Auto Parts initiates sale process for Worldpac and Canadian Business - The company has initiated separate sale processes for the potential divestiture of Worldpac and the company's Canada business. Worldpac, a leading automotive wholesale distributor of original equipment and aftermarket parts for all makes/all models, is highly recognized for its world class technology, catalog, product brand assortment and training. The company's Canadian business, which predominantly serves commercial customers, goes to market under the Carquest banner. The company has engaged Centerview Partners to assist in the sale processes. The company has not set a timetable for the conclusion of the sale processes and does not intend to comment on or provide updates regarding these matters unless and until the processes are concluded or it determines that further disclosure is appropriate or required.
|
ARDX | Hot Stocks06:41 EST Ardelyx treatment of pediatric hyperphosphatemia granted orphan status - A treatment of pediatric hyperphosphatemia being developed by Ardelyx was granted FDA orphan status, according to a post to the agency's website. Reference Link
|
ALE | Hot Stocks06:34 EST Allete's Minnesota Power issues RFP for up to 300MW of solar energy - Minnesota Power, a utility division of Allete, took an important step in advancing its EnergyForward vision for 100% carbon-free energy with the issuance of a Request for Proposals for up to 300 megawatts of regional solar energy to come online by 2027. The RFP follows Minnesota Power's 2021 Integrated Resource Plan approved by the Minnesota Public Utilities Commission, which calls for the company to acquire up to 300 megawatts of regional solar generation capacity. The procurement of solar through this RFP will increase Minnesota Power's solar portfolio by tenfold and provide customers with renewable energy that will help the company and state meet carbon-free goals in the coming decades.
|
META... | Hot Stocks06:32 EST Lone Pine exited Nvidia during Q3, bought Meta and made top holding - Stephen Mandel's Lone Pine Capital disclosed last night in an SEC filing its holdings as of September 30, 2023. Lone Pine's four new buys during the third quarter included, by size of position, Meta Platforms (META), Alphabet (GOOGL), Tempur Sealy (TPX) and Block (SQ). Lone Pine's exited positions during the quarter included RH (RH), Visa (V), Nvidia (NVDA), Moderna (MRNA) and Sweetgreen (SG). Lone Pine's stakes in the quarter, by size of previous position, include MasterCard (MA), Salesforce (CRM), Bill (BILL), Amazon.com (AMZN) and Epam Systems (EPAM). Lone Pine's reduced stakes in Q3 include, by size of previous position, Bath & Body Works (BBWI), Microsoft (MSFT), Floor & Decor (FND), TransDigm (TDG) and Dick's Sporting Goods (DKS). Lone Pine's top holdings as of September 30, in order of size, were Meta Platforms, Amazon, MasterCard, TSMC (TSM) and Microsoft.
|
GPI | Hot Stocks06:31 EST Group 1 Automotive provides update on dividend, share repurchase plan - Group 1 Automotive announced its board of directors declared a quarterly dividend of 45c per share that will be payable on December 15 to stockholders of record as of December 1. The dividend is consistent with the company's previously announced increase of 20% in its annualized dividend rate from $1.50 per share in 2022 to $1.80 per share in 2023. The company also updated its year-to-date share repurchase activity of 678,743 shares of common stock at an average price of $233.31 for a total of $158.4M, which represents approximately 4.7% of Group 1's outstanding common shares at January 1. As of November 15, the company had $157.7M available under its current share repurchase authorization. Purchases may be made from time to time, based on market conditions, legal requirements, and other corporate considerations, in the open market or in privately negotiated transactions. The company expects that any repurchase of shares will be funded by cash from operations. Repurchased shares will be held in treasury.
|
ACLX GILD | Hot Stocks06:07 EST Arcellx to receive $200M investment from Gilead for ACLX-001 - Arcellx (ACLX) and Kite, a Gilead Company (GILD), announced that the companies have expanded their existing collaboration, which was originally announced in December 2022. Kite has exercised its option to negotiate a license for Arcellx's ARC-SparX program, ACLX-001, in multiple myeloma, which is comprised of ARC-T cells and SparX proteins that target BCMA. The companies have also expanded the scope of the collaboration for Arcellx's CART-ddBCMA to include lymphomas. Upon closing, Arcellx will receive a $200M equity investment to purchase 3,242,542 shares of its common stock, which is expected to extend the company's cash runway into 2027. Following this investment, Gilead's estimated ownership will be 13%. Arcellx will also receive an upfront non-dilutive cash payment of $85M at closing and will be eligible for potential milestone payments, including the advancement of lymphoma and the license for ARC-SparX, as well as additional milestones, to offset prespecified development costs over a limited period of time. The transaction is expected to close around year-end 2023. Closing of the transaction is subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act and other customary conditions. Beginning in the first quarter of 2022, consistent with recent industry communications from the U.S. Securities and Exchange Commission, or SEC, Gilead no longer excludes acquired IPR&D expenses from its non-GAAP financial measures. Assuming the transaction closes by year-end 2023, the company expects the transaction to reduce Gilead's GAAP and non-GAAP EPS by approximately 9c-11c per share.
|
HON | Hot Stocks06:07 EST Honeywell selected by AIBOT - AIBOT, a pioneer in eVTOL technology, announces it has selected Honeywell to integrate its Compact Fly-By-Wire system into AIBOT's aiEVTOL aircraft. This technological milestone combines groundbreaking eVTOL capabilities with robust, reliable, and advanced aerospace technologies. AIBOT is a California-based company with the vision to disrupt the next generation of Urban Air Mobility for all. Pushing the current trend towards electric, AI, connectivity and sharing through innovation and strategic partnerships, AIBOT's mission is to create a software-driven, AI-empowered, electric, shared and connected aiEVTOL ecosystem and autonomous capable aircraft that centers around transforming the passenger experience. AIBOT is a pioneer in aiEVTOL technology, dedicated to creating a connected, autonomous, and ultra-safe aircraft ecosystem.
|
IHRT | Hot Stocks06:05 EST iHeartMedia signs platform distribution and ad sales deal with iHeartMedia - Global has signed an exclusive platform distribution and ad sales deal with iHeartMedia. Under the exclusive deal, Global and iHeartMedia will license, distribute and represent each other's chart-topping Podcas portfolios. In the UK iHeartPodcasts, the No. 1 podcast publisher globally according to Podtrac, will be available on Global Player and via DAX, Global's market leading digital advertising exchange. iHeartPodcasts adds millions of downloads to Global Player and the DAX network.
|
ACLX GILD | Hot Stocks06:04 EST Arcellx, Kite expand partnership - Kite, a Gilead company (GILD), and Arcellx (ACLX) announced that the companies have expanded their existing collaboration, which was originally announced in December 2022. Kite has exercised its option to negotiate a license for Arcellx's ARC-SparX program, ACLX-001, in multiple myeloma, which is comprised of ARC-T cells and SparX proteins that target BCMA. The companies have also expanded the scope of the collaboration for Arcellx's CART-ddBCMA to include lymphomas. Upon closing, Arcellx will receive a $200M equity investment to purchase 3,242,542 shares of its common stock, which is expected to extend the company's cash runway into 2027. Following this investment, Gilead's estimated ownership will be 13%. Arcellx will also receive an upfront non-dilutive cash payment of $85M at closing and will be eligible for potential milestone payments, including the advancement of lymphoma and the license for ARC-SparX, as well as additional milestones, to offset prespecified development costs over a limited period of time. The transaction is expected to close around year-end 2023. Closing of the transaction is subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act and other customary conditions. Beginning in the first quarter of 2022, consistent with recent industry communications from the U.S. SSEC, Gilead no longer excludes acquired IPR&D expenses from its non-GAAP financial measures. Assuming the transaction closes by year-end 2023, it expects the transaction to reduce Gilead's GAAP and non-GAAP 2023 EPS by approximately 9c-11c per share.
|
SYM | Hot Stocks06:03 EST Southern Glazer's Wine & Spirits and Symbotic announce strategic agreement - Southern Glazer's Wine & Spirits and Symbotic, announced they have entered into a strategic agreement and intend to deploy Symbotic's A.I.-powered software and robotics warehouse automation systems in select Southern Glazer's distribution centers. The companies have agreed to implement the first of these systems by 2025. Symbotic's end-to-end automation system, with robotic case picking capabilities, enables Southern Glazer's to transform these distribution centers to improve fill rates, order accuracy and customer service times, while extending the capacity and useful life of its existing facilities. The Symbotic System will build mixed-case pallets for efficient route-stop delivery and more efficiently and accurately handle both high velocity and slow-moving inventory.
|
GENI | Hot Stocks06:02 EST Genius Sports expands agreement with FanDuel - Genius Sports announced an expanded agreement with FanDuel Group to deliver its BetVision streaming solution. FanDuel will unveil BetVision as part of its premium NFL offering through Genius Sports. As the exclusive distributor of NFL Official League Data, Genius Sports will continue to provide FanDuel with access to the league's proprietary Next Gen Stats, or NGS, data as well as the official sports betting data feed. BetVision will allow FanDuel customers on mobile and tablet devices to take their live NFL viewing experience to the next level in the FanDuel sportsbook app. By incorporating BetVision into the FanDuel Sportsbook, fans will be able to watch select NFL games inside the app featuring live stat tracking used by some of North America's largest broadcast and streaming partners.
|
GM | Hot Stocks05:57 EST GM's Cruise suspends supervised and manual car trips, expands probes - Cruise said on Tuesday it will pause all supervised and manual car trips in the U.S. and expand the scope of investigations at the robotaxi operator in the aftermath of an accident that initially led to the suspension of driverless vehicle operations. "This orderly pause is a further step to rebuild public trust while we undergo a full safety review," Cruise said in a blog post. "We will continue to operate our vehicles in closed course training environments and maintain an active simulation program in order to stay focused on advancing AV technology." The actions follow a regularly scheduled board meeting in San Francisco this week. Cruise also said that GM's Executive Vice President of Legal and Policy and Cruise board member, will be expanding his support of Cruise and working closely with Cruise CEO Kyle Vogt and the Cruise Senior Leadership Team to oversee the workstreams around Transparency and Community Engagement. Cruise's Legal & Policy, Communications, and Finance teams will report directly to Craig, and he will assume the title of Chief Administrative Officer for Cruise. He will continue in his current role at GM. Cruise also noted that it previously hired the independent, third-party engineering consulting firm, Exponent, to conduct a technical root cause analysis of the October 2 incident. That work is ongoing, and the Board plans to expand Exponent's remit to include a comprehensive review of our safety systems and technology. Reference Link
|
GOOG GOOGL | Hot Stocks05:47 EST YouTube to require disclosure when videos include generative AI - YouTube plans to require users to disclose when they have uploaded realistic-looking manipulated or synthetic content, including using AI tools, in 2024, the company said in a blog post on Tuesday. "Specifically, we'll require creators to disclose when they've created altered or synthetic content that is realistic, including using AI tools. When creators upload content, we will have new options for them to select to indicate that it contains realistic altered or synthetic material. For example, this could be an AI-generated video that realistically depicts an event that never happened, or content showing someone saying or doing something they didn't actually do. This is especially important in cases where the content discusses sensitive topics, such as elections, ongoing conflicts and public health crises, or public officials. Creators who consistently choose not to disclose this information may be subject to content removal, suspension from the YouTube Partner Program, or other penalties. We'll work with creators before this rolls out to make sure they understand these new requirements." Reference Link
|
NKE | Hot Stocks05:45 EST Nike increases quarterly dividend to 37c per share - Nike announced that its board of directors approved a quarterly cash dividend of 37c per share on the company's outstanding Class A and Class B Common Stock. This represents an increase of 9% versus the prior quarterly dividend rate of 34c per share. The dividend declared is payable on January 2, 2024, to shareholders of record at the close of business December 4.
|
HON | Hot Stocks05:41 EST Honeywell selected by Aibot to provide cFBW system to support its eVTOL aircraft - Honeywell has been selected by Aibot to provide its Compact Fly-By-Wire, or cFBW, system to support Aibot's fully electric vertical takeoff and landing, or eVTOL, aircraft. This Honeywell technology will empower the next generation of aircraft avionics and create a sustainable transportation ecosystem for the future. Honeywell's lightweight Compact Fly-By-Wire system, the size of a paperback book, provides aircraft manufacturers, like Aibot, greater flexibility in aircraft design without compromising power or safety. The system enables the removal of conventional mechanical linkages controlling the effectors, streamlining maintenance procedures, and reducing costs throughout the entire lifecycle of an aircraft. It also enables remote operation of the aircraft, translating instructions from the aircraft's operator into flight control commands on the aircraft. The system's envelope-limiting feature guarantees safe operations, making it particularly well-suited for stabilizing uniquely designed unmanned vehicles and delivering a stable flying experience.
|
RTX | Hot Stocks05:36 EST RTX signs 10-year agreement with Emirates - Pratt & Whitney, an RTX business, has signed a 10-year agreement with Emirates to maintain and support the airline's 116 PW980 auxiliary power units, or APUs, on its Airbus A380 aircraft. The PW980 APU is a two-shaft gas turbine engine specifically designed for the Airbus A380 wide-body jet liner. Pratt & Whitney Canada manufactures a comprehensive portfolio of APUs for both military and civil/commercial aircraft applications. Operated by more than 700 different operators worldwide, Pratt & Whitney Canada APUs help power over 7,000 aircraft in operation. Since its founding in 1928, Pratt & Whitney Canada engines have flown one billion hours.
|
MT | Hot Stocks05:33 EST ArcelorMittal enters additive manufacturing industry as steel powder supplier - ArcelorMittal announced its entry into the additive manufacturing, or AdM, market as a steel powder supplier. The company is building an industrial-scale inert gas atomizer in Aviles, Spain, to produce steel powders for AdM technologies such as laser powder bed fusion, or LPBF, binder jetting and direct energy deposition. The atomizer, which will start production in January 2024, will have a large batch-size production capability, from 200 kg to 3 tons, and an initial annual capacity of 1000 tons. This will enable ArcelorMittal to supply significant volumes of steel powders with consistent quality, reliability and traceability, meeting the high standards and specifications of the AdM industry. In line with ArcelorMittal's commitment to sustainability and decarbonization, the company is committed to advancing the sustainability of additive manufacturing. The atomizer will therefore produce powders from scrap steel, using renewable electricity, atomizing with industrial gases produced by renewable energy, and using recycled and recyclable packaging solutions. A new business unit, ArcelorMittal Powders, has been established to commercialize the output of the atomizer. The steel powders will be offered in size ranges suitable for all existing powder-based metal additive technologies in manufacturing industries such as aerospace, defense, automotive, medical, and energy. They can also be used in the latest technological developments such as the brake disc coatings being developed to help Automotive OEMs and Tier Ones comply with the EU7 regulation on particle emissions. A layer of powder deposited on the brake disc provides wear and corrosion resistance which significantly reduces the particulate emissions of braking.
|
NCNO | Hot Stocks05:29 EST nCino partners with OneSavings Bank on its cloud-based single platform - nCino announced a strategic partnership with OneSavings Bank, or OSB, to provide the institution with a cloud-based single platform that will help streamline traditional banking processes such as underwriting and loan origination. The partnership will support OSB as it further innovates its mortgage and lending operations via technology investments while maintaining a high level of customer service and regulatory compliance.
|
PSNY | Hot Stocks05:27 EST Polestar Automotive commences production of Polestar 4 - Polestar confirms the start of production of Polestar 4, with first deliveries to customers in China expected before the end of 2023. Official launch in all other Polestar markets is planned for early 2024, with customer deliveries in these markets expected within the same year.
|
GH | Hot Stocks05:25 EST Guardant Health to appeal intellectual property federal district court verdict - Guardant Health announced it intends to appeal yesterday's verdict in the U.S. District Court for the District of Delaware related to intellectual property claims brought against Guardant by TwinStrand Biosciences, Inc. and University of Washington. Guardant remains confident that it did not infringe the asserted patents, and the company expects to file additional motions with the U.S. District Court for the District of Delaware and appeal to the U.S. Court of Appeals for the Federal Circuit.
|
CMPS | Hot Stocks05:21 EST Compass Pathways initiates UK component of COMP360 psilocybin treatment - Compass Pathways announced the initiation of the UK component of its phase 3 program of investigational COMP360 psilocybin treatment in treatment-resistant depression, or TRD. The research will take place in multiple sites in the UK, including at the Centre for Mental Health Research and Innovation in London, which officially opened. The ongoing phase 3 program is the largest randomized, controlled, double-blind psilocybin treatment clinical program ever conducted and follows results from Compass's phase 2b study of COMP360 psilocybin treatment. The phase 3 program consists of two pivotal trials and each trial has an integrated, long-term outcomes component. COMP 006 will take place in the UK and globally and will study three dose arms of COMP360. COMP 005 is a US-based trial examining the effect of a single 25mg dose of COMP360 psilocybin, compared with placebo.
|
HPE | Hot Stocks05:14 EST HP Enterprise partners with Sauber Motorsport to advance aerodynamics - HP Enterprise announced that Sauber Motorsport AG is partnering with HPE to advance aerodynamics of its Formula One race cars. The teams jointly developed a high performance computing, or HPC, system for computational fluid dynamics, or CFD, which significantly increases computing performance compared to the previous system. Physically installed in the wind tunnel building of Sauber Motorsport AG in Hinwil, Switzerland, HPE delivers supercomputing performance as a service via HPE GreenLake, enabling Sauber's engineers to quickly adjust capacity in compliance with the rules of the International Automobile Federation, or FIA. Storing and processing all data in Sauber's protected environment in Hinwil helps the team safeguard its intellectual property and minimize latency.
|
MMC | Hot Stocks05:11 EST Marsh McLennan teams with Ukraine to insure Black Sea grain shipments - Marsh McLennan in collaboration with the Ukrainian government, the Export Credit Agency of Ukraine, Ukreximbank, Ukrgasbank and DZ Bank, announced the launch of a new facility - Unity - to provide affordable insurance supporting the export of grain and other critical food supplies globally from Ukraine's Black Sea ports. Underwritten by insurers based at Lloyd's of London, Unity will provide up to $50M in hull and separate protection & indemnity, or P&I, war risk insurance. Ukreximbank, the State Export-Import Bank of Ukraine, and state-owned Ukrainian bank Ukrgasbank will provide standby letters of credit, each confirmed by DZ Bank, to support the facility which itself is backed by the Ukraine Ministry of the Economy, providing shipowners and charterers with war risk insurance in the absence of safe corridors. Global law firm, Norton Rose Fulbright, provided advisory services.
|